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Plethysmography refers to the dynamic measurement of biological tissue volumes that,
for example, may change due to fluctuations in blood volume. Photoplethysmography (PPG)
makes use of the attenuation of light penetrating into vascular tissues to determine these changes
in blood volume. Modern PPG is an optical technique involving low cost photosensors and light
emitting diodes (LED), and is capable of measuring multiple biological vitals simultaneously.
For example, in addition to heart rate determination, PPG devices can be used as pulse
oximeters, capable of calculating the blood oxygen saturation (SpO ) through a series of simple
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optical calculations performed on either reflectance or transmittance data. In this project, a
reflectance-based PPG pulse oximeter was designed to collect blood volume measurements on
the foot of a patient. This project also involves using the PPG sensor to determine the effect of
vibrational signal on vasoconstriction in the tissue, to provide more information on biological
properties, including diabetic nerve damage. The device is constructed via dual wavelength light
sources and a phototransistor where the light sources are determined based on the isosbestic
point, for oxygenated and deoxygenated hemoglobin.
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CHAPTER 1
1.0

INTRODUCTION

The development design and utilization of a photoplethysmography sensor will be discussed
throughout the extent of this thesis. In America and throughout the world there is an increasing
number of health concerns. Some of the most common diseases such as cancer, heart disease and
diabetes, can be fatal and often require constant medical monitoring to ensure good health. As
technology advances, monitoring and assessing health is becoming easier and more accessible.
The development of point-of-care medical tools, capable of monitoring and providing instant
results, have led to the advance in medicine. These, small, compact, and easy to use medical
devices can provide quick and easy monitoring of vitals as well as provide instant results for
more advanced monitoring. Similarly, medical devices that are non-invasive and do not require
skin penetration excel above the rest due to the decrease risk of infection. Designing medical
devices should incorporate all of the described characteristics and should provide a tool that
makes medical diagnostics and monitoring easier and more convenient.

Diabetes, a major medical disease and a growing concern in the United States, is incurable and if
not treated appropriately can lead to adverse health effects. Continuous monitoring of the disease
is necessary to track patient’s health and monitor degradation. One of the most common effects
of diabetes is nerve damage and degradation. An electronic tuning fork can be used to determine
nerve damage caused by prolonged untreated diabetes. The tuning fork is an example of a
medical device that can be utilized remotely and provide accurate instant results. There are many
other medical devices widely utilized in the medical field, that monitor and evaluate vitals. The
ease of use of the device and the time to results are critical when it comes to the effectiveness of
these tools.

An electronic tuning fork is utilized as a point of care medical tool to evaluate nerve damage, in
diabetic patients. The project goal is to incorporate a blood oxygen sensor into the electronic
tuning fork, developing a device capable of evaluating the nerve damage and blood oxygen
1

levels. The device becomes more critical to doctors as it now provides two medical statistics
instantaneously. Throughout the extent of this thesis the design and development of a blood
oxygen sensor to incorporate into the electronic tuning fork, will be discussed in detail. The
oxygen sensor is designed optimize the signal and provide doctors with more accurate results.
The combined device will be beneficial to the medical field, and give doctors a faster and easier
way to tests and evaluate patient health.

1.1

The Importance of Medical Device Technologies

As technology advances in all fields of science, the development of more versatile and compact
medical diagnostic devices becomes available. Measuring biological vitals such as heart rate,
body temperature and blood pressure are important indicators of one’s health. A specific
example of vital sign abnormality is heart rate variation, which can be an indication of many
health concerns such as, the effects of disease, chemical imbalances, or other biological
abnormalities. Monitoring heart rate can provide an indication of detrimental clinical health
events, such as heart failure, or abnormal heart rates (e.g. Tachycardia, Arythmias, or premature
contractions). If a patient is experiencing a continuous heart rate above 100 beats per minute, this
is faster than normal, and known as tachycardia[1]. Monitoring patient vitals can be critical to
determining health and can indicate serious medical abnormalities. According to a number of
studies, changes in vital signs occur several hours before a serious adverse event[2]. It is
important to constantly monitor vital signs; heart rate was provided as an example, but all health
statistics are useful in determining the health of a patient. The importance of monitoring vital
signs is evident, but the frequency and how best to monitor them is often disputed[2]. A study
performed at a hospital in England determined that 31% of preventable deaths were a result of
poor clinical monitoring[3]. Providing easy to use medical devices capable of monitoring vitals
could lead to, earlier indication of a critical event, more extensive monitoring of disease
progression, and better prolonged tracking of ill patients.

Diabetes causes degradation in many systems throughout the body, the disease is a result of high
blood sugar which can lead to kidney failure, destruction of blood vessels and nerve damage.
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The disease causes severe autonomic dysfunction leading to sudden cardiac death, continuous
monitoring of heart rate can decrease this risk[4]. Many diseases can cause heart failure, often
seen as abnormalities in heart rate, leading medical device companies to explore a number of
approaches to continuous monitoring of vitals [1]. Over time this has resulted in increased device
mobility and utility, tending towards decreased size and complexity.

Handheld devices such as personal digital assistants (PDAs) have become increasingly popular
in the medical field[5]. Many PDAs involve recording and tracking information at point-of-care
testing, allowing medical data to be stored throughout patient interaction. Point of care (POC)
technologies have increased in popularity over the last 40 years, due to the changes in health care
to deliver convenient and cost effective aid[6]. Most POC technologies are chemical diagnostic
testing, such as blood glucose or other handheld fluidic testing devices, these usually require a
finger prick or some invasive measure to acquire the biological material for testing. More
popular POC devices include non-invasive technologies such as pulse oximeters, breathalyzers
and other biological monitoring devices[7]. These compact non-invasive POC medical devices
support growth in biological monitoring technologies. New non-invasive medical monitoring
technologies give doctors easy to use testing devices with rapid results.

1.1.1

The Combination of Medical Devices to Advance Patient Care

As POC, and other medical devices become more capable, there is an increasing number of tools
utilized to monitor and measure vital signs. Doctors will often evaluate multiple tests and vital
monitoring to get a more in depth understanding of the patient’s health. There are usually
multiple devices needed to collect different vital statistics. For example, heart rate is measured
using an ECG, blood pressure with a pressure cuff, temperature with a thermometer, etc.
Combining various medical devices to incorporate all monitoring at once, not only reduces
monitoring time, but provides paralleled medical results. For example, there are benefits of
monitoring blood oxygen and heart rate simultaneously, as the blood oxygen decreases, heart
rate might increase in attempts to provide more oxygen to the body. Measuring multiple vitals
simultaneously provides doctors with more diagnostic information without needing to preform
3

multiple tests. A study evaluating patient vital signs found that patients with one abnormal value
had an in-hospital mortality rate of 0.9% but if the patient had three abnormal values they had an
in-hospital mortality rate of 24%[3]. Combining medical devices to monitor an assortment of
biological vitals is efficient but difficult to execute. It is challenging to design a single accurate
medical device with two separate devices that have varying points of contact, different biological
collection processes and inconstant data acquisition techniques. All of those differences are
important when designing handheld medical devices with numerous medical capabilities.

1.2

Diagnostics for Diabetic Neuropathy

Neuropathy of the lower extremities resulting from diabetes is a growing concern in the US with
serious consequences. According to the CDC, 26.9 million people in the United States have been
diagnosed with diabetes[8]. A result of prolonged untreated diabetes is neuropathy, where the
nerves degrade due to lack of blood flow from increased blood glucose levels. Diabetic
neuropathy usually starts as a loss of sensation in the extremities but can manifest into pain and
inability to judge temperature. Further nerve damage can lead to atrophy (loss of muscle) in
lower extremities resulting in loss of function and deformation[9]. Diabetic neuropathy is an
extremely common disease, research suggests about 50% of those diagnosed with diabetes will
develop peripheral neuropathy[6]. It is also suggested that it is impossible to accurately
approximate the prevalence of the disease due to the variation in diagnostic criteria. A common
practice for evaluating diabetic neuropathy involves vibratory sensation, where a 128-Hz tuning
fork is held on the bottom of the foot. An abnormal response is recorded when the patient loses
sensation and the examiner can still feel the vibration, the examiner will give a score between 0
and 3 depending on the extent of nerve damage[11].

4

Figure 1.1: [A] Percentage of US population diagnosed with diabetes from 1958-2015. [B] Number of US population diagnosed
with diabetes from 1958-2015. Image reproduced from [12]

Because diabetes is one of the most common diseases there are many methods to indicate how
the disease is advancing in the body. As we discussed above neuropathy is a significant adverse
effect of the disease measurable by a vibrational signal. Another result of diabetes is degradation
of blood oxygen to the peripherals. Diabetes causes blood flow to decrease and many of the
extremities to lose blood circulation, leading to the neuropathy. It is important to monitor blood
oxygen in the extremities to evaluate the degradation of blood circulation. The combination of a
tuning fork utilized on the foot of a diabetic patient that is also capable of monitoring the blood
oxygen would be beneficial to further understand the extent of the diabetes in the patient.

1.3

Project Specific Aims

The Electronic Tuning Fork (ETF) is an example of a handheld medical sensor that can deliver
POC diagnostics to a patient. The device is used to test the extent of neuropathy (damaged
nerves) in patients who have diabetes. The ETF produces quantitative data to the extent of nerve
damage and eliminates testing with tuning forks. The device is a small compact instrument that
vibrates at specific frequencies, similar to the mechanical tuning forks. The ETF device is placed
on the foot at a high vibrational amplitude, and slowly decreases until the patient can no longer
feel the vibration. The time at which the patient lost vibrational sensation is recorded and
represents the extent of nerve damage. The ETF provides a controlled and accurate way to define
nerve damage. The device is designed to quantify the nerve damage and eliminate variation, seen
5

with the mechanical tuning fork, across doctors. Adding more medical diagnostic tools to the
ETF would advance the device potential and usability in POC treatment.

Todd O’Brien, DPM the founder of O’Brien Medical LLC, launched the first Electronic Tuning
Fork (ETF128) in 2015 and now has the more advanced ETFMX. O’Brien Medical LLC was
looking to advance the ETF by addition of a blood oxygen monitor to the device. O’Brien
connected with the University of Maine Bioengineering program to advance his device. I was
tasked with the project to develop a blood oxygen sensor that could integrate into O’Brien’s
electronic tuning fork.

Aim 1: The first goal of the thesis is to design a pulse oximeter to fit into the ETF, allowing the
examiner to collect information on the patients’ diabetic nerve damage and blood oxygen
saturation simultaneously using a single device. Construction of an operational blood oxygen
sensor requires reverse engineering of current pulse oximeters and evaluation of optimal optical
components. Research and evaluation of optical physics and light attenuation utilized to evaluate
oxygen saturation in the blood is necessary to ensure accurate device construction. After
research, optimal optical components, and device design are determined. The design of the
device must allow for integration into the ETF. Further construction requires development of
PPG boards created with the help from electrical engineers.

Aim 2: After designing an accurate blood oxygen sensor into the ETF, the final goal was to
redesign the tuning fork cap to optimize the designed sensor. This involves research and
understanding of light and it’s physical properties through dermal material. The goal was
designing a mechanical covering to optimize the amount of light that was penetrating into the
skin and returning to the sensor. Testing requires changing the direction of light using various
caps and evaluating the returned signal. 3D-printed caps must be designed to direct the light in
different directions and the pulse signal should be evaluated to determine the optimal direction of
light.
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CHAPTER 2
2.0

BACKGROUND

For the body to maintain homeostasis, all biological components need to be preforming
optimally adjusting to conditions and aiming for stability. There are many aspects of human life
that can be monitored to determine the state of homeostasis for an individual, such as vital signs
which are biological processes that can be observed. Therefore common vital signs are
temperature, blood pressure, heart rate (pulse) and respiratory rate. Other vital signs include
blood glucose levels, oxygen saturation, and pain. For example, a decrease in pulse, oxygen
saturation or temperature can indicate the human body is not operating correctly. If this data is
not captured quickly enough, further degradation can occur. This indicates that constant
monitoring of vitals can be crucial for saving lives. There are many ways to monitor vitals,
which have evolved over the years as technologies have likewise advanced. Today, there are a
multitude of sensors utilized in medical facilities to provide constant monitoring of critical
biological vitals.

Photoplethysmography(PPG) is an optical signal utilized in medical devices to monitor the heart
rate. The signal is a technique that has become popular across the advancing medical technology
field and is utilized across most hospitals today. PPG signal technique is applied in pulse
oximeters, by means of light absorption and reflection through biological tissues. As the heart
pumps blood throughout the body, it carries oxygen from the lungs to the tissues, and a pulsatile
signal can be generated from obstruction of light due to increased blood flow. The PPG signal is
a waveform which reflects the eb and flow of the heart pumping blood. The PPG signal is
derived from Beer’s law, where the incident of light exiting a material is proportional to the light
entering and the optical characteristics of the material itself.

Understanding the biological and optical components of blood, as well as the components needed
to optically record blood volume changes, a PPG signal can be generated. The PPG waveform is
utilized in pulse oximeters and is capable of determining the difference between oxygenated and
7

deoxygenated blood, thus providing blood oxygen saturation. The PPG signal utilized in pulse
oximeters is a critical tool to monitor and evaluate the health of an individual.

2.1

Significant Anatomy

Oxygen(O2) is a vital element to the human body, without it, homeostasis is not maintained, and
cells will begin to deteriorate. The process of supplying the body with oxygen relies on gas
exchange, which first occurs within the respiratory system, where pressure differences in the
lungs cause oxygen to be inhaled. Oxygen enters the blood and is transported throughout the
body by means of the heart. The pumping action by specific chambers in the heart facilitates the
movement of oxygenated blood from the lungs into the blood vessels, to transport it throughout
the body. The heart is a vital organ that is capable of self-regulating to the body’s cardiac output
needs. The heart pumps blood from the lungs into first the arteries then the arterioles and finally
capillaries. Once the oxygenated blood reaches the capillaries gas exchange occurs and oxygen
from the red blood cells (RBCs) is transferred to the tissues.

2.1.1

Blood and Circulatory System

Blood makes up about 8% of the human body and aids in numerous functions to maintain
homeostasis, including regulation of pH, maintaining body temperature, and transportation of
vital nutrients throughout the body[13], [14]. Blood consists of two principal components,
plasma and formed elements depicted in figure 2.1. Plasma makes up about 55% of the blood,
and the formed elements account for the remaining 45%. The plasma portion of the blood is a
water-based a yellowish fluid that contains <10% of plasma proteins, such as albumin, and other
solutes[13], [14]. Of the formed elements in the blood, 95% are red blood cells (RBCs), the other
5% are white blood cells (WBCs) and platelets[14]. The WBCs provide protection against
infections and disease, platelets coagulate to prevent bleeding, and RBCs transport nutrients and
waste[15].
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Figure 2.1: Separation of blood, and approximate values of components in a normal adult.

Erythrocytes, or red blood cells (RBCs), primary functions are delivery of O2 to tissues and
removal of carbon dioxide(CO2) as waste[13]. RBCs shape is similar to a flat disc, but the
outside edges are thicker than the inside center to increase the cell’s surface area. The greater
surface area allows O2 and CO2 to diffuse across the tissues more rapidly and the thin center adds
flexibility to pass through smaller blood vessels[13], [14]. RBCs transport approximately 98.5%
of the O2 in the blood to the tissues, the other 1.5% is dissolved in the blood plasma[14].

The main component of RBCs is hemoglobin (Hb), which gives the cell the ability to transport
oxygen. The hemoglobin molecule consists of four globin protein chains, each chain contains a
non-protein heme group illustrated in figure 2.2. Iron, in the heme, facilitates the binding of
oxygen (O2) molecules to the RBCs, because the hemoglobin molecule contains four irons it has
the capacity to bind four O2 molecules to each hemoglobin molecule[13]. Hemoglobin on the
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RBCs collect oxygen in the lungs and transport the gas to the tissues through the blood vessels.
Once the oxygenated RBC reaches the systemic capillaries the O2 molecule is released and a
CO2 molecule is collected. The RBC with bound CO2 then travels back through the blood vessels
to the lungs where the CO2 is exhaled[13]–[15].

When oxygen is bound to hemoglobin it is referred to as oxyhemoglobin(HbO2) and has a bright
red appearance[14]. Another form of hemoglobin is deoxyhemoglobin (Hb) where no oxygen is
bound to the heme group on the RBC. Some hemoglobin molecules have lost the ability to bind
oxygen and lead to limited oxygen supply.

Figure 2.2: The Red blood cell is comprised of a hemoglobin molecule which contains 4 chains each with an iron group. The iron
group on the chains binds to the oxygen in the lungs and transports it to the tissues.

All tissues utilize O2 to operate and perform biological tasks, because of this RBCs are vital to
maintain biological homeostasis, without them tissues would not receive oxygen, coincidentally
diminishing functionality.
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2.1.2

Respiratory System

The respiratory system in the body consists of an upper respiratory tract and a lower respiratory
tract. The upper tract consists of the external nose, nasal cavity, pharynx, and associated
structures, and the lower respiratory tract includes the larynx, trachea, bronchi, and lungs[13],
[14]. Humans have two lungs located below the ribs in the upper trunk of the body. Each lung
is branched off into lobes called lobar bronchi, which are further segmented into bronchioles,
terminal bronchioles and finally alveoli[14]. Alveoli are small air filled chambers that facilitate
gas exchange in the blood[14].

Figure 2.3: Anatomy of the lungs; two lungs a left and a right are separated from the trachea by the bronchi, within the lungs the
bronchi segregate into bronchioles, leading to the alveoli. The alveoli are responsible for the gas exchange between lungs and
the blood, facilitating CO2 removal from blood to be exhaled and diffusion of O2 inhaled into the blood.

Ventilation, the process of moving air in and out of the lungs, is divided into inhalation and
exhalation[14], [15]. Respiratory ventilation is governed by principles of flow and pressure, the
difference between the external pressure (atmospheric) and the pressure inside the lungs
(intrapulmonary pressure) drives inhalation and exhalation[13]. Air enters the body and travels
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through the lungs into the alveoli, where the O2 readily transfers into the blood and CO2 transfers
from the blood to the lungs to be exhaled[13]. The alveoli have a thin membrane surrounded by
pulmonary capillaries containing deoxygenated blood[15]. The transfer of gasses, or gas
exchange is driven by the physics of partial pressure, where elements will flow to maintain
equilibrium[13]. After inhalation the partial pressure of oxygen (Po2) is higher in the alveoli
then in the surrounding capillaries, thus driving the diffusion of oxygen from the lungs into the
blood[16]. The reverse will happen for the CO2 where the partial pressure of CO2 (Pco2) in the
lungs is lower than the Pco2 in the blood, thus the CO2 from the blood will flow into the lungs
and be exhaled[16].

Oxygen travels from the lungs into the blood and binds to the hemoglobin, once bound the
oxygen is carried to the tissues where it released it in the systemic capillaries[15]. The
hemoglobin binds or disassociates with the oxygen molecule depending on the surrounding
partial pressure of oxygen[14]. In the systemic capillaries the Po2 is lower than the Po2 of the
blood, causing the O2 molecule to disassociate with the hemoglobin and move into the tissue.
Partial pressure of oxygen and hemoglobin oxygen saturation (So2) depict the bodies ability to
use and transport oxygen.
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Figure 2.4: The oxygen-hemoglobin dissociation curve. Representing a healthy subject with a normal blood hemoglobin (Hb)
concentration. The y- axis represents the hemoglobin saturation as a percentage, and the x-axis shows the partial pressure of
oxygen in the blood. The Hb is highly saturated when the PO2 is at high, and when the PO2 is low the Hb saturation is low. The
correlation is not and when the PO2 is high the Hb saturation does not change significantly, but when the PO2 declines the
hemoglobin saturation fall rapidly. Image reproduced from[16].

The saturation of oxygen (So2) is relative to the number of binding sites on a hemoglobin
molecule[16]. Consequently, A hemoglobin macromolecule that is 100% oxygenated indicates
that all four binding sites on the hemoglobin molecule are bound to oxygen, if only two O2
where bound the hemoglobin would be 50% and so on[13]. The oxygen-hemoglobin dissociation
curve illustrates the percent saturation of hemoglobin to the partial pressure of oxygen shown in
figure 2.4. Generally when the Po2 increases this is followed by a rise in the oxygen
saturation(So2) [16]. Because the dissociation curve is considerably flat when the Po2 is greater
than 90%, an increase in Po2 has minimal effects on the hemoglobin saturation. In contrast when
the Po2 is below 90% the hemoglobin saturation drops substantially[16]. The optimal oxygen
saturation is between 94-98%[16].
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2.1.3

Cardiovascular System

The cardiovascular system along with the circulatory system are responsible for the movement of
blood through the body. The heart pumps oxygenated blood from the lungs to blood vessels
which travel throughout the body to deposit oxygen. The heart and blood vessels are capable of
regulating blood flow and optimizing oxygen transportation.

The heart consist of four chambers, two ventricles and two atria, left ventricle and left atria and
right ventricle and right atria[13]. The ventricles are responsible for pushing blood out of the
heart to the connecting arteries, thus the ventricles are of greater muscle mass than the atria. The
left side of the heart acquires oxygenated blood from the lungs and pumps it throughout the
body, whereas the right side of the heart obtains returning deoxygenated blood and pumps it to
the lungs[14]. The atrioventricular valves (AV) regulate the opening between the atria and the
ventricles.
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Figure 2.5: Anatomy of the heart, the left atrium fills with blood from the lungs and travels into the left ventricle, the two
chambers are divided by the mitral valve. The left ventricle is responsible for contracting and forcing blood throughout the body.
On the right side of the heart is the right atrium, responsible for collecting returned blood with CO2, and the right ventricle. The
right chambers are divided by the tricuspid valve, the right ventricle contracts to send deoxygenated blood to the lungs to be
exhaled.

The cardiac cycle refers to the continuous pumping action of the heart and consists of a complete
contraction and relaxation of all four chambers[13], [14]. The cardiac cycle describes the
movement of blood through the heart and consists of multiple phases but is often divided into
systole and diastole. The terms systole and diastole refer to the contraction and relaxation of the
ventricles [14]. Blood first enters the heart through the pulmonary veins, where blood
oxygenated from the lungs flows passively into the left atrium. The first phase of the cardiac
cycle is ventricular filling where the ventricles are relaxed (diastole) and the AV valves open
causing blood from the atrium to flow into the left ventricle[13]. During ventricular filling the
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atrium will contract to facilitate complete filling of the ventricle[13], [14]. At the end of this
phase each ventricle contains an end-diastolic volume (EDV) about 130mL of blood[13]. The
second phase in the cardiac cycle is isovolumetric contraction, where the atria relaxes, and the
ventricles begin to contract. The slight contraction of the ventricles causes the AV valves to
close and cease the blood flow from the atrium to the ventricle[13]. This forceful closing of the
AV valves and vibrations from this cause the first heart sound often referred to as a “Lub” [13],
[14]. The third stage of the cardiac cycle is ventricular ejection commonly referred to as systole.
In this phase the ventricles forcefully contract increasing the pressure beyond that of the
connecting arteries. The semilunar valves open and the blood in the ventricles is driven into the
arteries, generating a spike in the aortic pressure[13].

Not all of the blood in the ventricles is ejected into the arteries, the EDV is about 130mL and
only about 70mL is expelled, this is known as the stroke volume (SV)[13]. The amount of blood
left in the ventricle after total ventricular ejection is the end-systolic volume (ESV), about 54%
of the blood is ejected into the arteries[13]. During high intensity exercise the percent ejection
can be as high as 90%[13]. The final phase of the cardiac cycle is isovolumetric relaxation,
where the ventricles enter diastole and relax. As the ventricles relax a minimal amount of blood
from the arteries flows back into the ventricles, this force prompts the semilunar valves to close
creating a slight rebound in the aortic pressure, known as the dicrotic notch[13].
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Figure 2.6: Heart contraction Cardiac Cycle starts with the passive flow of blood into the atrium once the blood fills, the atrium
contracts forcing blood into the ventricles, the valves between the atrium and the ventricles close and the ventricles begin to
contract, when the ventricles contract blood is forced out of the heart and into the body.
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As the heart pumps, cycling through the cardiac cycle, blood is forced into the arteries. When the
left ventricle contracts blood is forced out of the heart and into the circulatory system via the
aorta. The increased blood volume into the aorta forces blood throughout the body, this increases
the volume not only at the arteries but throughout all of the circulatory system components. The
blood volume throughout the body pulses with the beating of the heart, allowing for heart rate
monitoring in all locations with constant blood supply, even the capillary beds.

Variations occurring in the cardiac cycle, also known as arrhythmias, can be attributed to heart
failures and lead to death. One benign example of this is premature ventricular contraction
(PVC), which interrupts normal heartbeats and causes an irregular pulse. Although PVC can lead
to more serious rhythm disturbances that are most often harmless, and detected as a miss beat or
a “flip-flop” in the chest[17]. There are various other arrhythmias that are indications of harmful
cardiac problems and can be detected as variations in the heartbeat.

2.2

Review of Clinical Techniques for Monitoring Blood Perfusion Vitals

Blood perfusion is necessary to sustain life, it is responsible for the transport of oxygen, nutrients
and waste throughout the body[18]. Abnormalities in blood perfusion are used to identify and
diagnose biological conditions, consequently monitoring this vital sign is important to sustained
health. Blood flow or blood perfusion can be utilized to monitor many vitals such as, heart rate,
blood oxygen saturation and blood pressure.

The observation of blood perfusion and blood monitoring techniques have been around for
hundreds of years and are still utilized in modern medicine. The first measured heartbeat was
said to have been discovered by Herophilus of Alexandria, Egypt (c. 335-280 BC) who designed
a water clock capable of timing the pulse[19]. As technology and medical understanding
advanced, so did the ability to monitor biological vitals and in the late 1800’s the first ECG was
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discovered by physician Willem Elbthoven[19]. Since then, the monitoring of pulse and other
blood perfusion vitals have advanced throughout medical history. Today technology has
advanced tremendously providing easy and affordable access to blood flow monitoring
techniques.

2.2.1

Clinical Applications of Heart Rate Monitoring

The clinical need for compact, non-invasive, and easy to use, heart rate monitors has increased
throughout medical history. Heart rate is the most important vital that can indicate biological
failure, and although heart disease was the leading cause of death in the United States in 2017,
there are many other diseases that affect heart rate[20]. Sudden cardiac death (SCD) accounts for
25% percent of the deaths in cardiac patients, monitoring heart rate variability can indicate
problems before death occurs[21].

Heart rate is most frequently monitored using an EKG (ECG), in hospital settings, that records
the pulsatile signals of heart contractions. Healthy heart beats are characterized as a “lub – dub”
sound, but there are many instances where the heartbeat is abnormal. An abnormal heartbeat is
referred to as an arrhythmia. There are many causes of arrhythmias, and they usually indicate
that the heart is not functioning properly. The most common causes of out-of-hospital cardiac
arrest are arrhythmias, specifically, ventricular tachycardia and ventricular fibrillation. If
ventricular fibrillation goes undetected, and untreated the arrhythmia is usually fatal[22]. In the
medical field monitoring heart rate is critical for patient care. There are many practices utilized
for monitoring heart rate, as technology advances these devices have become increasingly more
advanced and versatile.
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2.2.1.1 Manual Heart Rate Measurement.
There are several techniques that exist for monitoring the heart rate, the most traditional is
manually counting the beats at an artery that is close to the surface. The most common arteries
that are used for this technique are the radial artery located at the wrist, and the carotid artery on
the neck. The manual method requires placing two fingers on either artery and counting the
number of pulses that occur in over 15 seconds, then multiplying this number by 4 to get the
number of beats per minute(bpm). A healthy adult normally has a resting heart rate between
60bpm to 100bpm[14].

Figure 2.7: Visual descriptions of the manual heart rate measurement method on the carotid artery (left) and the radial artery
(right). Image reproduced from [23].

2.2.1.2 Digital Heart Rate Sensors.
The common method for measuring heart rate is digital heart rate sensors. Before the invention
of pulse oximeters digital heart rate monitors were known as electrocardiograms (EKG or ECG).
An ECG detects electrical changes in the heart using electrodes attached to the skin[13]. The
electrodes pick up electrical impulses created by the heart during the cardiac cycle and then
amplify the signal on an electrocardiograph[13]. The ECGs utilize the electrical impulses from
heart contractions to detect heart rate, via electrodes that attach to the skin. These electrodes
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from an ECG can cause irritation to the skin or burns. The ECG monitoring systems require
multiple electrodes to be attached to the chest, back and abdomen, requiring time and effort to
attach. Due to the limitations of ECG, this system is less optimal than optical non-invasive heart
rate monitors in accessibility[24].

Instead of using electrical signals like the EKG, current pulse oximeters use optics: a less
invasive technology to monitor the heart rate. The pulse oximeter device is usually applied to the
finger and uses light perfusion across the tissue to measure heart rate. The pluses oximeters and
other digital heart rate monitors use photoplethysmography(PPG) signals to interpret heart
rate[23]. This method of monitoring heart rate is most commonly used today and can also be
found in many commercially available technologies including watches and headphones.

2.2.2

Clinical application of Blood Oxygen Monitoring

As discussed in the previous chapter the blood oxygen saturation (SO2) is a crucial vital sign
that, when low, can indicate that oxygen is not readily being transported throughout the body.
The brain is considered the most sensitive organ, if hypoxemia, or low SO2, occurs, the brain
does not get enough oxygen, and visual, cognitive and electroencephalographic changes can
occur[25]. There are many methods to measure SO2, or arterial blood oxygen saturation (SaO2),
the percentage of bound oxygen in the arteries. Some methods utilize the transcutaneous tissue or
peripheral blood to estimate the SaO2 by measuring the peripheral oxygen saturation (SpO2).
SpO2 is often utilized for SO2 measurement because of its similarities to SaO2 and ease of
measurement compared to arterial blood.

Blood oxygen saturation characterizes how blood is being transported and reaching the tissues.
In June of 2017 the BTS Guideline for Oxygen use in Adults in Healthcare and Emergency
Settings indicated that healthy individuals between the ages of 18 to 81 should have an arterial
blood oxygen saturation (SaO2) in the range of 94%-98%[26]. Throughout history there have
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been many methods of measuring peripheral blood oxygen saturation (SpO2) values including
chemical methods, electrical PO2 sensors, and other light attenuation oximeters.

2.2.2.1 Van Slyke Method
The Van Slyke Method is a means of measuring oxygen content using chemical reactions. The
method requires a blood sample which is exposed to potassium ferricyanide which removes
carbon dioxide from the sample. The sample is then compressed, and pressure is measured using
a manometer[27]. After the CO2 is removed sodium hydrosulfite is introduced to the sample to
remove the remaining oxygen[28]. Van Slyke Method utilizes the Van Slyke apparatus to
manipulate the sample and measure the pressure after the chemical reactions. The apparatus
pictured in figure 2.8 uses mercury and a stopcock control to operate the chemical reactions and
pressure measurements[29].

Figure 2.8: The Van Slyke apparatus contains a stopcock and mercury(Hg) to measure the chemical reaction and determine the
oxygen saturation. Image recreated from [29]
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2.2.2.2 Clark Electrode and Transcutaneous PO2 Sensors
The Clark Electrode measures the partial pressure of oxygen PO2 using chemistry. Oxygen
dissolved in an aqueous solution is exposed to 0.7V. A silver anode in a potassium chlorine bath
will attract (Cl-) producing a constant flow of electrons, and a platinum electrode in the same
bath reacts turning oxygen to hydroxyl ions (OH-). The number of electrons used in the platinum
cathode is proportional to the PO2 value, thus the current across the electrodes corresponds to the
PO2 in the solution[28]. Later the Clark electrode was modified to be used, in vivo, as catheter
electrodes. There are many downsides to the Clark electrode including the need to draw blood
and the invasiveness of the vivo electrodes. There are often problems making sure the tip of the
electrodes stays clean and clear of any debris or congealed blood, and the most challenging
limitation of the device is the need for calibration using a separate blood gas analyzer.

Figure 2.9: Lenard Clark with his invention of defoaming in an oxygen bubbler that helped construct the Clark electrode. Image
replicated from [30]
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The Clark electrode can be placed on the outside of the skin to be utilized non-invasively. The
transcutaneous partial pressure of oxygen (PtcO2) can be measured to indicate the arterial partial
pressure of oxygen PaO2. The Clark electrode is heated on the skin, inducing hyperemia and
increasing the blood flow to the affected area. The increased blood flow causes more O2 to be
diffused across the skin more easily, causing the PtcO2 to approach PaO2[28]. Although the
transcutaneous sensor is less invasive than then Clark electrodes it still has some disadvantages.
The heating of the sensor takes approximately 10mins and has risks of burring, in infants it is
suggested to be moved every 4 hours[28].

2.2.2.3 Arterial Blood Gas Analyzer
The arterial blood gas test measures the concentration of gases like oxygen and carbon dioxide in
the blood. The arterial blood gas analyzer was developed by Dr.Severinghaus and his technician
in 1958, using the technology involved in the Clark electrode. Dr.Severinghas modified the Clark
electrode and combined his own research, measuring pCO2 and pH, into one analyzer to develop
the arterial blood gas test[30]. The technology advanced throughout the years and by the 1960’s
the device was universally available. The analyzer requires arterial blood, usually withdraw from
the radial artery but in some cases, it is extracted from the brachial or femoral arteries. The
extracted blood must be kept warm and tested within 30 minutes of taking the sample. Since the
1960’s the device has advanced and can be utilized today to measure oxygen saturation in cases
such as shock, hypothermia, or kidney failure where other non-invasive oxygen monitors are less
accurate. Although the oxygen saturation data from an arterial blood gas test is extremely
accurate, the test takes time, and because the blood oxygen saturation within the body can
change instantaneously, the results from the test can be skewed. Because of the tests’s inability
to perform instant measurements and requires a large blood gas analyzer, other non-invasive
techniques have surpassed.

2.2.3

Pulse Oximeters

Pulse oximeters utilize light interaction to measure blood oxygen saturation and have become the
most popular instrument to do so in medicine today. The first modern pulse oximeter was
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developed in 1972 by Takuo Aoyagi and Muchio Kishi, who discovered the ratio of red to
infrared light absorption through the tissue. After the discovery of the light ratio to measure
oxygen concentration, and the tremendous advance in technology of that time, the pulse oximeter
was constructed as an easy method for monitoring blood oxygen saturation. Monitoring real time
oxygen saturation is critical to patient health, blood oxygen saturation can drop to critical limits
within seconds. Pulse oximeters offer a convenient, non-invasive method for measuring blood
oxygen saturation continuously[25].

Figure 2.10: Finger pulse oximeter, most commonly used in hospitals, the device is placed over the finger to read heart rate and
blood oxygen saturation.

Current on market pulse oximeters are small enough to be placed over the finger, as seen in
figure 2.10. The instrument contains micro lights which interact with the peripheral blood flow,
as the heart beats the lights detect changes in blood volume. Pulse oximeters are a compact easy
to use device that measures blood oxygen saturation and heart rate. Pulse oximetry continues to
be a critical component of standard of care monitoring for critically ill patients[31].
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2.3

Photoplethysmography

Photoplethysmography(PPG) is an optical signal, produced by blood perfusion at the
microvascular bed of the tissue[32]. PPG signals are utilized by wearable non-invasive devices
known as pulse oximeters[33]. Pulse oximetry and PPG are often confused, but pulse oximetry
is an application of photoplethysmography[15]. A photoplethysmograph is the waveform
generated by blood volume changes from the pulse signal[34]. Changes in the blood volume are
synchronous with the heartbeat, so the device can be used to calculate the heart rate[32].

The PPG device utilizes light emitting diodes (LEDs) of different wavelengths and
photodetectors, these components lead to the instruments small-scale and affordable
characteristics[35]. Most PPG sensors are transmission-based, where the LEDs and the
photodetector are located on opposite sides of the tissue. The relevant sensor in this thesis uses
reflected-based PPG, where components are on adjacent sides. The LEDs beam light into the
tissue where it interacts with biological material, and the light is either absorbed or scattered
away. Scattered light can travel back to the sensor where the photodetector detects the light
exciting the tissue[15].

A PPG signal can be obtained using two LEDs at different wavelengths, this signal is used to
calculate peripheral oxygen saturation (SpO2). Each wavelength of light interacts with materials
differently, thus the SpO2 can be calculated from the variation of the two LEDs’ interaction with
the tissue.

2.3.1

Photoplethysmograph Waveform

During the cardiac cycle the heart contracts pushing blood throughout the body[13], [14]. When
the heart contracts this is known as systole, during this phase the blood is forced out of the heart
and into the arteries. The force of the blood moving out of the heart causes a buildup in pressure
throughout the arteries and an increase in blood volume in the capillaries[15]. As the volume in
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the tissue increases the amount of light from the LED hitting the photodetector will decrease,
thus causing the absorbance to increase. When the heart is relaxed in diastole the opposite will
occur, the blood volume at the tissues will subside and more light will be detected on the
photodetector, less absorbance[15]. This is the basic concept of the photoplethysmography
waveform.

2.3.2

Theory of spectrophotometers

Spectrophotometry is the basis for all oximetry and the theory behind the PPG signal[28]. The
spectrophotometer measures the absorption of light through a substance at a particular
wavelength[28]. Spectrophotometers use a photodetector to measure the intensity of light that
has passed through the substance.

Figure 2.11: A spectrophotometer is comprised of a white light source which passes through monochromator scattering the light
into all wavelengths, the spectrum of light then passes through an adjustable aperture to narrow the field of view. The light is
then projected into the sample of interest, on the opposite side of the sample is a photoresist and an amplifier. Once the light hits
the sample some is absorbed and some if reflected the reflected light is detected by the photoresistor amplified and displayed.
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The transmission (T), the amount of light passing through the material, is a dimensionless
quantity that can be calculated using equation 2.1 by dividing the intensity of incident light (I0)
by the intensity of light transmitted through the material (I).
!

𝑇=!

Equation2.1

!

The absorbance (A), the amount of light absorbed by the material can also be calculated using
the intensities of light before and after passing through a material:
𝐴 = 𝑙𝑜𝑔

!!

Equation 2.2

!

Beer’s Law, which is derived from the absorbance and transmission equations, is utilized to
calculate characteristics about the material light is passing through.

Beer’s Law is as follows:
𝐴 = 𝜀(𝜆)𝑐𝑑

Equation 2.3

Where 𝜀(𝜆) is the extinction coefficient of the substance at a given wavelength 𝜆 , c is the
concentration of a substance and d is the path length the light travels through that substance[28].
Beer’s Law is the fundamental governing equation for spectrophotometry and PPG sensors, as it
provides a mechanism to calculate the concentration of a material. Spectrophotometry is the
technique utilized in PPG sensors to calculate the concentration of oxygen in the blood. In the
upcoming chapters the use of Beer’s Law to calculate SO2 will be discussed in greater detail.
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2.3.3

Photoplethysmogram Correlation to Heart Rate

Although there are many devices to measure heart rate, such as ECG monitoring systems, PPG
sensors are considered low cost, portable, non-invasive and applicable in various
environments[36]. The PPG sensors are also capable of monitoring for heart rate variations to
predict cardiac issues or abnormalities[36]. The PPG sensor can detect the pulsatile signal of
blood volume changes due to the heart rate (HR) via the photodetectors modulation from the
original light signal[24]. The attenuation of light energy is dependent on the transmission or
reflection of light in the bloodstream, and correlates to systole and diastole in the cardiac
cycle[24]. The PPG waveform derived from variations in light absorbance can be seen in figure
2.12.

Figure 2.12: Photoplethysmogram where the amplitude correlates to the absorbance of light. The absorbance is related to the
beating of the heart, when the hearts is in systole the absorbance is high and in diastole the absorbance is low. Image
reproduced from [24]

From figure 2.12, illustrating the PPG waveform, the time interval between the systole pulses in
the cardiac cycle (t1) can be used to calculate the instantaneous heart rate in equation 2.4:

𝐻𝑅"#$% =
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Equation 2.4

The heart rate can be averaged over a period of time to increase accuracy of calculation.
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Equation 2.5

Where 𝑄## is the number of samples of normal intervals 𝑁𝑁 over time interval [𝑇" , 𝑇3 ].

The PPG signal can use the pulses from the increased blood volume to calculate the heart rate.
Most pulse oximeters or PPG devices today display not only SO2, but also heart rate, because of
its critical correlation to body health.

2.3.4

Acquisition of Photoplethysmography Signal

Light from the LED’s in a photoplethysmography sensor interacts with biological tissues. This
interaction can be complex involving scattering, absorption and/or reflection[37]. The
technology utilized for collecting and evaluating a PPG signal can vary across devices. It is
important that PPG signal devices use correlating components and wavelengths that interact with
blood.

2.3.4.1 Measurement Modalities
Transmission and reflection are the two most prevalent types of PPG sensors. Transmission
based sensors (Figure 2.13 (a)) are designed such that the LEDs are located above the finger, and
project light through the extremity. These sensors are constrained to a clip, placed on the earlobe
or finger where light can pass through the tissue [32]. On the contrary reflection based PPG
sensors (Figure 2.13 (b)) do not utilize light passing through tissue, and theoretically can be
positioned at any skin surface [32]. For the means of this thesis, the constructed PPG sensor
utilized a reflection-based design.
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Figure 2.13: Two types of PPG sensors (a)Transmission based where the light source and the light detection component are on
opposite sides of biological tissue and (b)Reflection based where the light source and the light detection component are on the
same side of biological tissues. Image reproduced from [24]

As light passes through the tissues it reacts with materials in the body, causing light to scatter in
different directions. For both types of sensors there are advantages and disadvantages, a
transmission-based sensor must have enough light entering the tissue to ensure the light interacts
with the blood and passes through the extremity. Because light travels through an extremity in
transmission-based sensors, the results can be skewed from external light, and why most
transmission sensors are designed to fully enclose the extremity, blocking out all light. The
transmission sensor is widely utilized on the medical market today, the “clip” design eliminates
variations that are found in a reflective PPG sensor.

Reflective PPG sensors detect scattered light that propagates back toward the light source, this
allows for more compact and easier to use sensors. The reflective sensors can be used where
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transmission sensors cannot, the sensors can be used virtually anywhere where vascular skin
exists on the body, whereas the transmission-based sensors are limited to areas where light can
attenuate through tissue i.e. earlobe, or finger[38]. The reflective based sensors do have some
disadvantages including, movement of the tissue on the sensor, and pressure applied, both can
cause variation in the PPG signal. Eliminating or decreasing the extent of the reflective sensor
disadvantages could cause this sensor type to progress beyond transmission.

2.3.5

Components of the Photoplethysmograph

As light enters the tissue it is absorbed and reflected by all of the biological components in the
tissue. The skin, bones and arterial/ venous blood are primary absorbers of light[28]. As the
heart enters systole blood flows to the extremities and the incidence of light reaching the sensor
is decreased, when the heart relaxes the blood volume in the extremities decreases and the light
increases [37]. The PPG signal is formed from two components AC and DC [24]. The pulsatile
signal produced from the PPG waveform is known at the AC component and can be seen in
figure 2.14 superimposed on the DC component [39]. The DC component, or non-alternating
component of the signal represents the constant components of the tissue like skin pigmentation
and bone material. The AC component represents the blood volume changes from a heartbeat,
each peak to peak signal represents a single heartbeat.
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Figure 2.14: PPG signal from electrical components, the AC signal is the pulsatile variation due to changes in blood flow and
the DC component of the signal is stagnant from the absorption of other biological components. Image reproduced from [23].

Within a single heartbeat the AC component is considered the maximum absorbance, and the DC
as the minimum, therefore the AC and DC are the peak and baseline of the PPG waveform
respectively[36]. In the past the variation in the AC and DC components generated a challenge
for consistent detection of blood volume changes, but the use of two wavelengths of light and
calculating a ratio of AC to DC signal components, the variation in the signal can be normalized
for a reflective based PPG sensor[37]. Further analysis of the AD to DC ratio will be discussed
in later chapters.

2.4

Optical Components of Photoplethysmography

Optics are the primary component in a PPG sensor, they are responsible for transmitting and
detecting light through tissue. Blood in the vascular bed of the tissue contains oxyhemoglobin
(HbO2) a red blood cell fully saturated with oxygen molecules, and deoxyhemoglobin (Hb) blood
without oxygen. The LEDs in the PPG sensor interact with the HbO2 and Hb to determine the
percentage of oxygen saturated blood.
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2.4.1

Principles of Photoplethysmography Oxygen Saturation

Peripheral oxygen saturation (SpO2) is an important biological reference characterizing oxygen
content in the blood, and the ability to transport the oxygen throughout the body. Oxygen
saturation calculation shown in equation 2.6, expressed as a percent the concentration of
oxygenated hemoglobin (HbO2) over the concentration of oxygenated hemoglobin plus
deoxygenated hemoglobin (HbO2 + Hb).

"#$

!
𝑆𝑝𝑂! = "#%"#$
× 100%
!

Equation 2.6

Pulse oximeters use PPG signals to measure the blood oxygen saturation (SpO2), by using Beer’s
Law to calculate the concentration of oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) in the
blood. The sensor uses two distinct wavelengths of light which interact with HbO2 and Hb
differently, in turn providing differentiation between the two concentrations. How various
wavelengths of light interact with HbO2 and Hb can be seen in figure 2.15, across the wavelength
spectrum the interaction with the oxygenated and deoxygenated hemoglobin varies.
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Figure 2.15: Extinction coefficient, related to absorbance, vs wavelength of light, for oxygenated (HbO2) and deoxygenated (Hb)
blood. The oxygenated and deoxygenated blood cross at two points throughout the light spectrum, these are indicated by red dots
and are referred to as isosbestic points.

A similar graph illustrating the absorbance of HbO2 and Hb for wavelengths in the 600-1000nm
range can be seen in figure 2.16, where lower wavelengths of light (600-700nm) HbO2
absorption is less than the absorption of Hb, and at higher wavelengths (850-1000nm) HbO2
absorption is greater than Hb. The wavelengths between 600-700nm are in the red region of the
spectrum, and the 850-1000nm wavelengths are in the non-visible infrared region. The variation
in absorbances is due to the isosbestic point, around 805nm, where the absorption effect shifts.
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Figure 2.16: Extinction coefficient, related to absorbance, vs wavelength from 600nm to 1000nm, for oxygenated (HbO2) and
deoxygenated (Hb) blood. The isosbestic point is located at 800nm before this point Hb has a high extinction coefficient than
HbO2 and after this point Hb has a lower extinction coefficient than HbO2. Image reproduced from [36]

In pulse oximetry the most common wavelengths of light utilized are 660nm and 940nm, any
wavelengths can be used as long as they fall on either side of the isosbestic point. Beer’s Law
relates the concentration of a material to the absorption, using this concept the SpO2 can be
calculated. The concentrations of HbO2 and Hb which make up the SpO2 equation can be
calculated using Beer’s Law:

𝐴 = 𝜀𝐿𝑐

Equation 2.7

Absorbance is equal to the extinction coefficient (𝜀) times the path length of light (L) times the
concentration of the material (c). Using two wavelengths of light a ratio of absorbances can be
calculated via Beer’s Law (equation 2.7) the ratio becomes:
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Equation 2.8

Where the ratio of light is equal to the absorbance of light at wavelength 1 (𝐴4+ ) over the
absorbance at wavelength 2 (𝐴45 ). From figure 2.16 the absorbance at l1 (red) for oxygenated
blood is less than the absorbance at l2, thus when the blood is highly oxygenated (SpO2=100%)
the ratio (R) will be less than 1 (approximately 0.4). If the blood is not oxygenated (Hb) the
absorbance at l1 is greater than the absorbance at l2 and the ratio will increase, a R=1
corresponds to an SpO2 value of approximately 85%.

2.4.2

Photoplethysmography Biologically Applied Absorbance Ratio

The light penetration depth in the skin depends on the tissue’s absorption and scattering
properties, also known as the extinction coefficient [32], [35]. Because absorption is dependent
on the wavelength of light, the LED’s in a PPG sensor require a specific wavelength to penetrate
deep enough and acquire blood oxygen information. A PPG sensor measures the concentration of
HbO2 and Hb in the blood using specific wavelengths of light, so it is critical that the
wavelengths penetrate through the tissue to reach the blood, and correlate to different HbO2 and
Hb absorbances.
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Figure 2.17: Depth of penetration vs wavelength of light, the wavelength of light directly correlates to the depth of penetration
into the tissue. The larger wavelengths of light penetrate deeper than the lower wavelengths.

From figure 2.17 it can be noted that greater wavelengths of light penetrate through tissue to
reach the layer of tissue containing blood. To collect PPG signals light penetrating the tissue
must be of a wavelength capable of reaching the vascular tissue bed. Fortunately, as discussed in
the previous section, the wavelengths of light utilized in PPG sensors are 660nm (red) and
940nm (infrared), two wavelengths capable of reaching the vascular bed containing blood.
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2.4.3

Photoplethysmography Electrically Applied Absorbance Ratio

As discussed in the previous section a PPG signal is divided into two components, the pulsatile,
AC component, and the constant background, DC component, or the maximum and minimum of
a single PPG waveform respectively. The two LEDs utilized in a PPG sensor have distinct AC
and DC components in the absorbance, seen in figure 2.18.

Figure 2.18: Dual PPG signal where one signal is from light in the infrared wavelengths(IR) and the other from red wavelengths
(R). The AC and DC components of each signal are defined, AC(---) and DC (––).

Where there are two PPG waveforms one IR (infrared) and the other R (red), to calculate the
ratio of absorbances the signal becomes:
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Equation 2.9

The ratio of the AC and DC components cancels the absorbance of other components in the
tissue such as bone or skin, and the ratio of the red light over the infrared light is used to
calculate the SpO2, discussed in later sections.

2.4.4

Oxygen Saturation and Beer’s Law

Using Beer’s Law and the ratio derived from the absorbance of light through the tissue the SpO2
can be calculated.

Peripheral oxygen saturation (SpO2) is defined as:
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Equation 2.10

Where the SpO2 is equal to the concentration of HbO2 over the total hemoglobin concentration
(HbO2 + Hb) times 100. This equation is usually written as a concentration:
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Equation 2.11

The SpO2 is represented as a concentration of the oxygenated hemoglobin (CO) and
deoxygenated hemoglobin (CD) over the total concentration CT in the blood. Using Beer’s Law
and equation 2.11 the oxygen saturation can be calculated from the absorbance of light in a PPG
sensor.
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The Beer’s Law, equation 2.12, relates the concentration and extinction coefficient of a material
at a specific wavelength to absorption of light.

𝐴 = 𝜀𝐿𝑐

Equation 2.12

Absorbance is equal to the extinction coefficient (𝜀) times the path length of light (L) times the
concentration of the material (c). Beer’s law can be represented with respect to oxygenated and
deoxygenated blood in the following equation

𝐴 . = 𝐴$ + 𝐴- = 𝜀. 𝐶. 𝐿 = 𝜀$ 𝐶$ 𝐿 + 𝜀- 𝐶- 𝐿

Equation 2.13

Where the total absorbance (AT) is equal to the absorbance of HbO2 (AO) plus the absorbance of
Hb (AD). Equation 2.13 can be expanded using equation 2.12, replacing the absorbances with
extinction coefficients, concentrations and pathlengths. The path length of light is equivalent for
Hb (D) and HbO2 (O) and therefore does not require differentiation within the equation and can
be eliminated from evaluation. Solving for 𝜀0 in equation 2.13, the equation becomes

𝜀. =
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Equation 2.14

Where extinction coefficient total 𝜀! is defined by the HbO2 and Hb extinction coefficient

𝜀" and 𝜀# respectively, the concentration of HbO2 and Hb, CO and CD and, the total
concentration which is the summation of CO and CD. rearranging the equation 2.14:
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Equation 2.15

Replacing CO and CT in equation 2.15 with SpO2 from equation 2.11, the extinction coefficient
total becomes:

𝜀. = 𝜀$ 𝑆𝑝𝑂! + 𝜀- (1 − 𝑆𝑝𝑂! )

Equation 2.16

Blood oxygen saturation is represented by the total extinction coefficient, a known value
determined by the material and wavelength of light utilized.

Substituting Beer’s law equation 2.12 into the ratio of light absorbances the equation becomes:
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Equation 2.17
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Where the ratio of absorbances is directly proportional to the ratio of extinction coefficients, and
it was determined equation 2.16 that the total extinction coefficient is equal to
𝜀0 = 𝜀6 𝑆𝑝𝑂5 + 𝜀7 (1 − 𝑆𝑝𝑂5 )
Substituting the equation for the extinction coefficient total, equation 2.16, into the ratio of
extinction coefficients, equation 2.17, the ratio becomes:
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Equation 2.18

Solving equation 2.18 for SpO2 the equation becomes:
𝑆𝑝𝑂! =

'/# /3'/!
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Equation 2.19

The blood oxygen saturation (SpO2) is represented in terms of the ratio (R) of absorbances for
the two wavelengths and the extinction coefficient of HbO2 oxygenated hemoglobin (𝜀" ) and Hb
deoxygenated hemoglobin (𝜀# ). Where the extinction coefficients of oxygenated and
deoxygenated hemoglobin are known values for the wavelengths utilized.

The relationship between the measured absorbances of light and the calculated theoretical SpO2
value can be plotted as a calibration curve figure 2.15, where the normalized ratio, R, represents
the ratio of absorbances of red to infrared wavelengths of light.

Figure 2.15: Oxygen saturation (SO2) versus the normalized ratio R, described in equation 2.17 as the ratio of absorbances of
two wavelengths of light through blood. Image reconstructed from [40]

The ratio of light absorbances to oxygen saturation is not a linear regression but is often
represented as one because of the close correlation. Representing this correlation linearly yields
the following linear equation:
𝑆𝑝𝑂! = 110 − 25𝑅
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Equation 2.20

Where the oxygen saturation is equal to 110 minus 25 times the normalized ratio. R represents
the ratio of absorbances, described above in equation 2.17.
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CHAPTER 3
3.0 DESIGN OF REFLECTANCE BASED PHOTOTPLETHYSMOGRAPHY SENSOR
This thesis investigates the design and development of a reflective based photoplethysmography
(PPG) sensor. A custom-designed sensor was constructed to acquire PPG signals. A PPG sensor
or pulse oximeter consists of two LEDs and one photosensor. The two LEDs of different
wavelengths penetrate the tissue, once the light reaches the blood it is either absorbed or
scattered. The scattered light signal is then detected by the photosensor and the light absorption
can be determined. For this thesis the PPG sensor was designed to be utilized on the foot no
greater than 13mm in diameter. The dual-wavelength PPG sensor is designed with a red
wavelength LED and an IR wavelength LED 660nm and 940nm respectively. Because the
sensor is restricted to 13mm in diameter, it is critical that the LEDs are powerful enough to
penetrate through the tissue and small enough to fit within the sensor. The absorption,
determined from the light detected by the photo sensor, from the two LEDs are used to calculate
peripheral blood oxygen saturation SpO2. It is important to utilize LEDs with a narrow
wavelength range to eliminate variation in the SpO2 calculations, this is especially critical for the
660nm LED, due to the steep slope of Hb in the extinction curve[28].

The absorbance of light, calculated from the PPG signal, is divided into AC and DC components,
where the AC component is the pulsatile peak and the DC the steady valley. The 660nm and
940nm LED both have an AC and DC component, and the amount of light absorption correlates
to the SpO2. The desire is to optimize the 660nm and 940nm signal by increasing the distance
between the peak and valley of the signals, or AC and DC components. The layout of the optical
components within the sensor greatly impacts the outcome of the PPG signal. If the optical
components are too close together the light will saturate the photodetector and the signal will not
have any pulsatile data, and if the components are too far apart the light signal reflected off the
tissue will not reach the sensor. The distance between the LEDs and the photosensor directly
relate to the signal to noise ratio of the PPG signal. Optimizing the distance between the optical
components improves the signal to noise ratio by increasing the AC to DC signal ratio.
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The physical distance between optical components is not the only design characterizing to
advance the PPG signal, electronics resistance is altered to reduce noise. Depending on the
sensor components the optimal resistance can be calculated and utilized to control the detected
signal. Most pulse oximeters or PPG sensors contain photodiodes as the photosensor, but a
phototransistor was selected due to its increased sensitivity[28]. A phototransistor operates
varying current in response to light, this is then converted to a voltage signal.

Two dual-wavelength sensors were designed during the extent of this research, throughout the
report I will refer to two PPG sensors as Sensor-1 and Sensor-2. The major difference between
the two sensors is the number of photodetectors, commonly referred to as a photosensor. The
first design, Sensor-1, is designed with two photosensors, and the second design, Sensor-2, with
a single photosensor. Sensor-2, the final sensor design, was constructed due to failures that
occurred in Sensor 1, which are discussed in more detail throughout the chapter. Sensor-2 is also
a dual-wavelength PPG sensor, but only contains 1 photosensor.

3.1

Photoplethysmography Sensor-1

Sensor-1 is designed with two photosensors to simultaneously detect both wavelengths of light
reflected light from the LEDs. Sensor-1 contained four optical components divided into visual
light emission and detection and infrared light emission and detection. These 4 components were
printed on a 10mm printed circuit board (PCB), with intention to connect to an external
motherboard. The LEDs on the PPG sensor project light at wavelengths in the visual light
spectrum(380nm-740nm) and the infrared light spectrum(700nm-1000nm), with photosensors
capable of detecting the light reflected from those LEDs. In Sensor-1, two photosensors were
utilized, one to detect the visual light emission and the other to detect the IR light emission. This
would provide two signals for both wavelengths of light, and optimal for calculating SpO2.
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3.1.2

Optical Components of Sensor-1

The PPG sensor or pulse oximeter is designed with optical components to emit and acquire light
signals. The sensor contains light emitting diodes (LEDs) which emit light into the tissue, and
two phototransistors which detect the reflection of light. The PPG Sensor-1 is a dual-wavelength
sensor containing two LED’s of different wavelengths, one at 660nm and the other at 940nm. As
the LEDs emit light into the tissue the phototransistors detect the specific wavelength of reflected
light, which is converted into absorbance. The sensor is designed with two phototransistors, one
capable of detecting wavelengths of visible light and the other capable of detecting wavelengths
of infrared (IR) light. Because the ratio of absorbances is calculated from two pulsatile signals, it
is critical that the reflected light is detected as separate signals. If the PPG sensor had one
phototransistor capable of detecting both visible and IR light the result would be one signal
contains of both wavelengths of light seen in figure 3.1. The two photosensors allow the device
to detect both LED signals simultaneously. On the contrary a sensor with a single phototransistor
is designed to switch the LEDs on and off to accommodate for the sensor’s inability to
distinguish between IR and RED wavelengths.

Figure 3.1: (A) two photosensors capable of detecting light from two different LED wavelengths, resulting in two separate
absorbance signals. (B) one photosensor that detects both light wavelengths resulting in one signal comprised of both
wavelengths.

The optical components utilized in Sensor-1 can be divided into visual light acquisition and
infrared light acquisition. For visual light acquisition, Sensor-1 consists of a red LED and an
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ambient light sensor. The red LED (AP2012HD, Kingbright©, USA) has a peak wavelength at
660nm shows in figure 3.2, and the ambient light sensor (ALS-PT19-315C/L177/TR8, Everlight
Electronics Co Ltd., Taiwan) utilized can detect reflected emissions from the red LED. The
spectrum for the ambient light sensor, a phototransistor, can be seen in figure 3.3, having a peak
absorbance at 630nm and a sensitivity range from 390nm to 700nm. It is important to note that
the ambient light phototransistor has a sensitivity maximum of 700nm, indicating that the
photosensor will not be able to detect wavelengths of light greater than 700nm. Comparing the
emission and detection spectrums for the red LED and the ambient light sensor, figure 3.2 and
figure 3.3 respectively, it can be concluded the ambient light sensor will detect the 660nm signal
emitted from the LED.

Figure 3.2: Optical emission graph of the red LED in Sensor-1, (AP2012HD, Kingbright©, USA) labeled is red. Relative
intensity on the y-axis and wavelength on the x-axis, the red LED has a peak wavelength at 660nm.
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Figure 3.3: Absorption graph of the ambient light sensor utilized in Sensor-1, (ALS-PT19-315C/L177/TR8, Everlight Electronics
Co Ltd., Taiwan). On the y-axis is relative sensitivity and on the x-axis is wavelength of light. The ambient light sensor has a
peak sensitivity at 640nm.

Sensor-1’s infrared (IR) light acquisition consists of an IR LED and an IR phototransistor. The
IR LED (APT1608F3C, Kingbright©, USA) has a peak wavelength at 940nm illustrated in
figure 3.4. The IR phototransistor (PT15-21B/TR8, Everlight Electronics Co Ltd., Taiwan) is a
light sensor capable of detecting light emissions in the IR wavelengths. The IR phototransistor
has a peak detection wavelength of 940nm and a range from 730 to 1100nm figure 3.5,
indicating that the photosensor will not detect any wavelengths less than 730nm.
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Figure 3.4: Optical emission graph of the infrared LED in Sensor-1, (APT1608F3C, Kingbright©, USA), with relative intensity
on the y-axis and wavelength on the x-axis The infrared LED has a peek emission at 940nm.

Figure 3.5: Absorption graph of the infrared light sensor utilized in Sensor-1, (PT15-21B/TR8, Everlight Electronics Co Ltd.,
Taiwan), with relative sensitivity on the y-axis and wavelength on the x-axis. The infrared light sensor has a peak sensitivity at
940nm.

The specs, including dimensions and operating conditions for the LEDs and photosensors can be
seen in table 3.1 and 3.2 respectively.
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Table 3.1: Optical specifications for red 660nm LED and IR 940nm LED

Parameter
Dimensions

Red (660nm) LED

IR (940nm) LED

2.0 mm x 1.2 mm x 1.1 mm

1.6 mm x 0.8 mm x 0.75 mm

Peak Wavelength (IF=20mA)

660 nm

940 nm

Spectal Line Halfwidth (deltaY ½)

20 nm

50 nm

Luminous Intensity

1.2 mcd

-

Forward Current

40 mA

20 mA

Forward Voltage (IF=20mA)

1.85 V

1.2 V

Capacitance

95 pF

90 pF

100 mW

90 mW

5V

5V

-55 to +85 ºC

-40 to +85 ºC

Power Dissipation
Reverse Voltage
Operating Temperature
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Table 3.2: Optical specifications for visual photosensor and IR photosensor

Parameter
Type

Visual Photosensor

IR Photosensor

Phototransistor

Phototransistor

1.7 mm x 0.8 mm x 0.6 mm

3.2 mm x 1.5 mm x 1.1 mm (1206)

Peak Wavelength Absorbance

630nm

940nm

Sensitivity Wavelength range

390nm – 700nm

730-1100nm

-

-

Emitter-collector-voltage

Voltage range 2.5V to 5.5V

5V

Collector-emitter voltage

-

30 V

Collector Current

-

20mA

100nA

100nA

0.11 ms – 0.22 ms

-

75mW

75mW

-40ºC – +85ºC

-25ºC – +85º C

Dimensions

Half angle

Dark Current
Rise and Fall Time
Power Rating
Operating Temperature

Sensor-1 is designed with visual and infrared light subdivisions, each subdivision contains an
LED and a phototransistor. The visual light and infrared subdivisions contain the LED: red
660nm and IR 940nm, respectively. The visual light phototransistor has a detection range of
390nm – 700nm, allowing the photosensor to detect the emissions from the 660nm red LED but
not the 940nm IR LED. In contrast the infrared phototransistor has a range of 730nm – 1100nm,
facilitating the detection of the 940nm IR LED but not the 660nm red LED. The emission
intensity and the detection intensity of the LEDs and the phototransistors can be seen overlain
with respect to wavelength in figure 3.6. The visual light sensor detects the emissions from the
red LED but does not detect any emissions from the IR LED, and the IR light sensor detects
emission from the IR LED, but not the red LED. This is optimal for the data acquisition of the
sensor, allowing both emissions to be detected simultaneously, as separate signals.
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Figure 3.6: Absorbance and emission spectrum of the optical components utilized in Sensor-1, The visual light sensor is
indicated by the thick navy blue line, the red LED, the thin red line, the IR sensor the thick gray line and the IR LED, by the thin
dark red line. The graph illustrates the IR LED emissions are detected by the IR sensor, and the red LED emissions are detected
by the visual light sensor.

3.1.3

Electronic Development of Sensor-1

Sensor-1 electronics are implemented within a printed circuit board (PCB), containing throughholes and padding shown in figure 3.7. The padding is designed with specific dimensions to
allow the soldering of the SMD (surface mount device) LEDs and photosensors. The throughholes in the PBC are implemented to solder wires through the sensor and control the device
remotely. Sensor-1’s design meets the 11 mm diameter requirement and includes all 4 SMD
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optical parts with the appropriate connections. Not pictured, is the back side of the PCB, which
contains the resistors needed to operate the sensors and LEDs. The back of Sensor-1 is designed
with similar padding to solder the resistors needed to operate the sensor.

Figure 3.7: 3D -rendering of sensor-1 PBC, there are 4 optical components, two sensors and two LEDs, labeled on the board.
There are 4 pin- out holes in the board to wire each component.

The electronic schematic for Sensor-1 can be seen in figure 3.8, as mentioned above the back of
the PCB is designed with padding to accommodate the resistors, illustrated in the schematic
below. The sensor is designed to receive 5 volts of power, which is altered depending on
component requirements. The red LED and IR LED have a forward voltage 1.85V (at 40mA
forward current), and 1.40V (at 20mA forward current) respectively. Both LEDs require a
resistor to supply optimal voltage to the components, a 820ohm resistor is implemented between
the 5v and the LED leads. The phototransistor detection signal was optimized for both the visual
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and IR photosensors, a 10kOhm resistor was added between the provided power and the
photosensor.

The visual and IR photosensors are phototransistors, operate by changing current in response to
changes in light. The electronics involved with a phototransistor will be discussed in future
chapters, but it is important to note that a voltage divider is needed to acquire voltage signal
changes from a phototransistor. A voltage divider is implemented for both phototransistors with
a 10kOhm resistor utilized, seen in figure 3.8

Figure 3.8: Schematic of electronics for sensor 1. D1 and D2 are the Red and IR LEDs respectively, both LEDs require an
820ohm resistor, R1 and R2. The phototransistors Q1(visible phototransistor) and Q2(IR phototransistor) require a 10kohm
resistor; R3 and R4. All components are wired to ground.
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3.1.4

Failures and Limitations of Sensor-1

Sensor-1 was connected to an oscilloscope to evaluate and optimize the signal. Throughout the
oscilloscope testing it was discovered that the visual light sensor (ALS-PT19-315C/L177/TR8,
Everlight Electronics Co Ltd., Taiwan) was able to detect not only the red 660nm LED but also
the 940nm IR LED. The visual light sensor did specify that it had a range of 390nm-700nm and
would not be able to detect light greater than 700nm. Because the visual light sensor can detect
the IR (940nm) emission the sensor is unable to successfully differentiate between the emitted IR
signal and the red signal. Although it is optimal to have two separate photosensors capable of
detecting contrasting wavelength spectrums, it was difficult to find a photosensor with such a
limited detection range capable of fitting on a 10mm PCB. After evaluation of Sensor-1 design
and components it was determined the best method is to reconstruct the sensor utilizing smaller
electronic components and a single photosensor. It was decided to utilize the current ambient
light sensor as the sole phototransistor in the design of Sensor-2, because it was able to detect
both the IR 940nm and 660nm LEDs being utilized. With only one photosensor the new sensor
would have to utilize a sample and hold signaling technique to acquire signal from both LEDs.
The sample and hold signaling technique allows the sensor to quickly alternate between
collection of red and IR LED emissions and storing the data to generate a fluid emission graph.
When using the switch and hold signaling it is important to note the frequency of rise and fall
time of the phototransistor, as well as the rate of emission of the LEDs.

Further testing of Sensor-1 identified that the visual light sensor actually acquired a higherquality signal from the IR LED emission than the red LED emission. The red emission was noisy
and low because the LED was not as bright as the IR(940nm) LED. Re-evaluating the LEDs
utilized in Sensor-1, it was determined that the IR LED has a greater luminosity than the red
LED. For Sensor-2 a higher luminosity red LED with the same wavelength was utilized to
provide more light penetrating the tissue and returning to the sensor.

Even though it was decided that the IR photosensor would not be utilized in Sensor-2 it was
discovered, when the IR LED and the IR photosensor were enabled the PPG signal exhibited
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high amplitude, and high noise. The noisy signal from the IR phototransistor, was most likely a
result of the component distance. When designing a reflective biased PPG sensor, the distance
between the photosensor and the LED is critical to the acquired PPG signal. If the sensor and the
LED are too close the light emitting from the LED will be directly absorbed by the photosensor
before reaching the tissue, and the photosensor will be over saturated. If the LED is too far from
the photosensor there will not be enough reflected signal from the LED to reach the photosensor,
resulting in a low intensity noisy signal. The goal is to determine the optimal distance between
the photosensor and the LED to optimize and refine the PPG signal.

3.2

Photoplethysmography Sensor-2

The PPG sensor or pulse oximeter is designed with optical components to emit and acquire light
signals reflected from the tissue. The PPG sensor developed is a dual-wavelength sensor
containing two LED’s of different wavelengths. As the LEDs emit light into the tissue the
phototransistor detects the reflected light, which is converted into absorbance. Sensor-2, the
final sensor design, contains three optical components, two LEDs, with emissions in the visual
and IR light spectrum, and one photosensor. The photosensor utilized is a phototransistor, which
fluctuates current in response to changes in light. Most pulse oximeters or PPG sensors contain
photodiodes as the photosensor, but a phototransistor was selected due to its increased
sensitivity[28]. Sensor-2 components are implemented on a 10 3/8 mm dimeter circle printed
circuit board (PCB). The sensor components are controlled using an NI myDAQ with compatible
LabVIEW software. The software is capable of powering the LED’s, collecting the signal from
the phototransistor and evaluating the signal to calculate and produce an SpO2 value. Emissions
from the LEDs enter the tissue, respond to blood volume changes and backscatter to be detected
by the phototransistor. Once the reflected light is detected by the phototransistor, the response is
converted from current to voltage and collected into the mDAQ for further signal manipulation.

3.2.1

Optical components of Sensor-2

Similar to Sensor-1, Sensor-2 contains a red and IR LED, with emission at 660nm and 940nm,
respectively. Sensor- 2 contains a signal photosensor, the visual light sensor from Sensor-1 is
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utilized in Sensor-2, due to the ability to detect both the IR and red LED emissions. The
schematic of the Sensor-2 can be seen in figure 3.9, including the two LEDs, and the visual light
phototransistor. The system consists of optical, electrical and signal processing components, all
of which are designed together to generate a PPG signal and determine the SpO2.

Figure 3.9: Sensor-2 circuit board schematic, there are 6 pin-out connections from the board, pin-1 is power to the IR LED, pin2 is power to the red LED, pin-3 is ground, pin-4 is power to the phototransistor, pin-5 is acquisition from the phototransistor
and pin-6 is open.

The 660nm red LED (SML-LX0603SRW-TR, Lumex Opto/Components Inc., USA) selected for
Sensor-2 has a peak wavelength at 660nm and a 0805 surface mounting package (1.6 mm x 0.8
mm x 0.60 mm). The 940nm IR LED (APT1608F3C, Kingbright, Taiwan) selected for Sensor-2
has a peak wavelength at 940nm and a range of 50nm. The specifications for the IR and red
LEDs are indicated in table 3.3.
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Figure 3.10: Emission spectrum of the red and IR LED respectively, with relative sensitivity on the y-axis and wavelength on the
x-axis. The red LED has a peak wavelength of 660nm and the IR LED has a peak wavelength of 940nm.
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Table 3.3: Optical and electrical characteristics of the red (SML-LX0603SRW-TR) 660nm LED and the IR (APT1608F3C)
940nm LED respectively

Parameter

Red LED

IR LED

Dimensions

1.6 mm x 0.8 mm x 0.6 mm

1.6 mm x 0.8 mm x 0.75 mm

660 nm

940 nm

-

50 nm

Luminous Intensity

15 mcd

-

Forward Current

40 mA

20 mA

Forward Voltage (IF=20mA)

1.7 V

1.2 V

Peak Wavelength (IF=20mA)
Spectal Line Halfwidth (deltaY ½)

Capacitance
Power Dissipation
Reverse Voltage
Operating Temperature

90 pF
50 mW

90 mW

5V

5V

-40 to +85 ºC

-40 to +85 ºC

The phototransistor in Sensor-2 detects light reflected from the tissues and in response the
current traveling across the component changes. The PPG sensor contains the surface mount
ambient light sensor (ALS-PT19-315C/L177/TR8, Everlight Electronics Co Ltd., Taiwan)
utilized in Sensor-1, capable of sensing a wide range of emissions. The spectral range for the
phototransistor is unknown but, discovered from failures in Sensor-1, is capable of detecting
both 940nm IR LED and 660nm red LED emissions.
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Table 3.4: Optical and electrical characteristics of the (ALS-PT19-315C/L177/TR8) phototransistor

Parameter

Phototransistor

Peak Wavelength

630 nm

Sensitivity Wavelength range

-

Half angle

390nm - ~1100nm

Emitter-Collecter- voltage

2.5 V – 5.5 V

Dark Current

100 nA

Rise and Fall Time

0.11 ms – 0.22 ms

Saturation Output Voltage

4.5 V

Power Rating

75mW

Reverse Voltage

5V

Operating Temperature

-40ºC to +85 ºC

3.2.2

Electrical Development of Sensor-2

The PPG sensor is an optoelectronic sensor containing a dual wavelength light emission, a
photodetector and a microprocessor system (MS). The PPG sensor developed in this thesis
utilizes a National instruments myDAQ and LabVIEW as the microprocessor system. The
optical components are mounted onto a custom printed circuit board (PCB) no greater than
11mm in diameter. Within the 11mm maximum diameter the board contains two LED’s and a
phototransistor, which are separated to an optimal distance. The design of the PCB and the
orientation of the components is crucial to the PPG signal. In reflective-based PPG sensors the
distance between the LED’s and the photosensor must be optimized to ensure the most accurate
data is collected. The absorbance of the light will change as the distance between the optical
components changes. The distance should be such that the maximum(AC) and minimum(DC)
components of the PPG signal can be differentiated[28]. If the LEDs are too close to the
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phototransistor, light from the LED will be detected by the phototransistor before reaching the
tissues, thus producing a PPG signal with no information about the blood volume and high
background noise. The background noise is known as the DC component of the PPG signal, or
the valley produced by the heartbeat as seen in figure 2.18. When the DC amplitude is greater
than the AC amplitude (peak) noise will saturate the signal and the AC signal will be
indistinguishable. A study was done by Mendelson and Ochs, investigating the optimal
separation distance between the components and the results are shown in figure 3.11 [40].

Figure 3.11: The separation distance of the photosensor relative to the LEDs on a PPG sensor with respect the AC (○) and DC
(□) components of the PPG signal. The y-axis represents the amount of reflected AC and DC signal as a voltage from a
photosensor. The distance between the light sensor and the LEDs should be no less than 4mm and no greater than 11mm. Image
recreated from [38].

Figure 3.11 indicates that if the LED and photosensor are 12mm apart the amplitude of the AC
and DC component is low, and no light is reaching the phototransistor. As the separation
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distance between the components decreases the AC amplitude increases and becomes
distinguishable from the DC component. The graph also illustrates, the DC intensity increases
over the AC component as the separation distance is minimized, indicating saturation of the
phototransistor. The study suggests a minimum of 4mm and a maximum of 11mm separation
distance between the optical components is capable of increasing the PPG amplification twofold[38].

A printed circuit board (PCB) contains of copper-based layers between non-conductive
materials, the model supports electronic components and connections made through etching track
or pads in the PCB. Altium Designer (Altium Ltd, Australia) was utilized to design and construct
the PCB. After the PCBs were designed the boards were ordered through OSHPARK (Oshpark
LLC, United States), a PBC board manufacturer. Figure 3.12 contains two CAD images, (A) and
(B), illustrating the front and the back of Sensor-2’s PCB design, respectively. The front of the
PCB (figure 3.12-A) contains four padding sites on the right and two padding sites on the left.
The right padding sites are for the IR and red LEDs and the left is for the photosensor. The back
of the PCB (figure 3.12-B) contains six padding locations, implemented for the addition of a
SMD conn Header (TSM-103-01-T-DV-TR, Samtec ©) seen in figure 3.13.

Figure 3.12: Printed Circuit Board layout for Sensor-2. (A) the top/front of the board indicating the soldering pads for the LEDs
and photosensor. (B) The back of the board illustrating the 6 pads for the SMD header, to facilitate wiring to the board and
components.
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Figure 3.13: The SMD 6position conn Header (TSM-103-01-T-DV-TR, Samtec ©) soldered to the back of sensor-2 PCB.

A computer-aided design (CAD) model of Sensor-2 can be seen in figure 3.14, containing the
phototransistor and both the IR and red LED. The model was designed in SolidWorks to
visualize the size and dimensions of the final sensor. The LEDs are approximately 4mm from the
phototransistor, the maximum distance attainable within the 11mm diameter board. As discussed
previously the distance between the photosensor and the LEDs is critical to the PPG signal
obtained. Anything less than 4mm would saturate the photosensor, so it was optimal to use the
extent of the board to maximize the distance between the components.
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Figure 3.14: 3D rendering of Sensor-2 housing the optical components, the two LEDs are located on the right side of the sensor
and the phototransistor on the left. The red LED is red, the IR LED is black, and the phototransistor is gray. The phototransistor
is located 4mm to the left of the LEDs, the maximum distance that the 11mm diameter sensor could accommodate.

The final sensor with the soldered optical parts is seen in figure 3.15, the phototransistor is
soldered to the padding on the left and the LEDs on the right. The distance between the two
LEDs is insignificant because they will be alternating power, due to the use of a single
photosensor.
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Figure 3.15: Visual image of the front of the final sensor design (Sensor-2) with optical components soldered on, the two LEDs
are located on the right side of the board 4mm away from the phototransistor which is located on the left. The LEDs are labeled
on the board with “IR” and “RED” correlating to the IR LED and the red LED respectively.

Sensor-2 electronic connection schematic, depicted in figure 3.16, houses 6 pins connected from
the back of the PCB to terminals to control the components. The six pins consist of power to
both of the LEDs, power to the phototransistor, signal out from the phototransistor and ground.
An NI myDAQ is used to control the components from the pins and signal acquisition, from the
phototransistor.
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Figure 3.16: Pin layout for the control of Sensor-2, with two pins for power to the IR and red LEDs, labeled “IR” and “RED” in
the schematic, one pin for ground labeled “GRND”, and an in and out pin for the phototransistor labeled “PT IN” and “PT
OUT”

Figure 3.17 is the circuit diagram for the two LEDs, 3v supplied from the NI MyDAQ passes
through a 2.2kW resistor before passing through the LED and connecting to ground. This
schematic is the same for the IR (940nm) and red (660nm) LEDs.

Figure 3.17: Electronic schematic for the LEDs on the PPG sensor, the red LED labeled “RED LED” is supplied +3v from port1 on the myDAQ which travels through a 2.2kOhm resistor before powering the LED. The IR LED labeled “IR LED” is similarly
supplied +3v that passes through a 2.2kOhm resistor, form port-2 on the myDAQ. Both LEDs are then connected to a similar
ground port.

Sensor-2 utilizes a phototransistor as the photosensor, as mentioned above the phototransistor
changes current in response to light. Because of this a voltage divider is needed to receive a
voltage signal from the phototransistor. The schematic for this component can be seen in figure
3.18 where 5v is supplied to the phototransistor. The 5v passed through the phototransistor, to a
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10kW resistor and then connecting to ground to close the circuit. The phototransistor output
signal is measured between the phototransistor and the 10kW resistor.

Figure 3.18: Phototransistor electronic schematic +5v is supplied to the phototransistor from the myDAQ 5v pin, the PT is
powered and connected to ground via a 10kW resistor. The out signal from the phototransistor is collected between the
phototransistor and the 10kW resistor. The signal is acquired on the myDAQ via the analog input +1/-1.

The phototransistor circuit operates using the voltage divider, when there is minimal light hitting
the phototransistor, the voltage out signal will be low, as more light begins hitting the sensor the
voltage out will increase toward Vcc in this case +5v form the NI nyDAQ. The voltage out signal
will change as more or less light is hitting the sensor. Measuring the voltage out provides a signal
in response to more or less light hitting the sensor, representing the increase and decrease in
blood perfusion from the heart beating.

3.2.3

Signal acquisition and Processing (LabVIEW) of Sensor-2

The majority of signal processing is performed using National Instruments (NI) LabVIEW suite.
The LabVIEW suite contains a powerful graphical block coding software and compatible
external microcontrollers. The myDAQ, an external microcontroller in the LabVIEW suite, is
utilized to control the components of Sensor-2. The myDAQ is responsible for powering the
LEDs and the phototransistor, as well as receiving and analyzing the phototransistor signal. The
LabVIEW software processes the signal and relays controls to the myDAQ. figure 3.19
illustrates the signal flow from the sensor components to the LabVIEW software. One of the
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reasons LabVIEW is such a powerful software is because of its integrated graphical user
interface (GUI). For Sensor-2, a GUI created in the LabVIEW software, relays signals to the NI
myDAQ, which is connected to the sensor and controls the optical components (figure 3.19).

Figure 3.19: The schematic diagram for the PPG sensor processor includes a National Instrument myDAQ which receives and
feeds information to the LabVIEW GUI and software. The myDAQ not only powers the two LEDs and the phototransistor, but
also acquires signal from the phototransistor.

The majority of PPG sensors utilize an external motherboard that controls the components, but
for the extent of this thesis it was optimal to utilize the LabVIEW suite to optimize the signal. In
a PPG sensor signal processing is a critical component, the control of the LEDs, the signal
transmitted to the phototransistor, the signal acquired from the phototransistor as well as the
signal calculations all need to be optimized to generate a selective PPG sensor.
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CHAPTER 4
4.0

SIGNAL PROCESSING

As blood volume changes due to the heart rate, more blood reaches the extremities and the
phototransistor reacts to more or less light hitting the sensor. This signal can be manipulated to
optimize the information. There are many signal manipulation processes utilized in PPG sensors,
the majority are applied utilizing a variety of electronic components, and a microprocessor. In
some sensors additional electronic components are designed to amplify, filter and sort the data
appropriately before the signal is processed by an external microprocessor. Figure 4.1 is a
general signal manipulation flow diagram for a PPG sensor, for each component in the schematic
the signal is optimized for the ratio calculation. The phototransistor signal is processed through
an initial amplifier to reduce the signal to noise ratio (S/N). As discussed in previous chapters the
phototransistor cannot differentiate between the red and IR LED signals, so a sample and hold
mechanism is utilized to separate the signals. The sample-and-hold mechanism is triggered by
the LED states, for example when the IR LED is on the sample-and-hold is collecting the IR
signal, and vice versa. The separate components are individually processed through a filter, and
the DC offset is determined. The separate signals are then amplified individually and compared
to calculate the AC/DC ratio.
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Figure 4.1: General PPG signal manipulation, signal received from the Phototransistor enters an amplifier to increase the signal
received, the signal is then manipulated using the sample and hold technique were the signal is divided into IR and Red signals.
Both signals are filtered and normalized by evaluating the DC off-set, after normalization the AC component of the signals are
amplified, the data is then collected, and the ratio is calculated.

The majority of PPG sensors manipulate the signal via electronic components, for the sensor in
this thesis all of the signal optimization and calculation is executed using the NI myDAQ and
LabVIEW processing suite. The NI myDAQ and LabVIEW software are capable of controlling
the PPG sensor components as well as manipulating the signal similar to electronic components.

4.1 LabVIEW and My DAQ Component Control
LabVIEWTM stands for Laboratory Virtual Instrument Engineering Workbench and is a systemdesign platform for visual programing from National Instruments©. All of the necessary
components for signal manipulation described in figure 4.1 are processed using LabVIEW. The
NI package uses a myDAQTM an external data acquisition device to acquire signals. The
myDAQTM is paired with the NI LabVIEWTM software, where the signals acquired from the
myDAQTM are processed. The schematic in figure 4.2 describes the signal processing for the
PPG sensor.
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Figure 4.2: The LabVIEW Programing suite is responsible for relaying information the NI myDAQ which provides power to the
LEDs and the phototransistor. Data from the phototransistor is acquired through the myDAQ and processed in the programing
software. The signals and controls are processed and viewed through the LabVIEW GUI.

The LabVIEW program encompasses all of the signal manipulation involved in a PPG sensor,
the signal manipulation in figure 4.1 is indicated in figure 4.2 as LabVIEW software. Signal from
the LabVIEW software is sent to the NI myDAQ where the signal is relayed to drive the LEDs
and the phototransistor. The information received from the phototransistor is collected through
the myDAQ and processed in the programing software and displayed through the programs
graphical user interface (GUI).

72

4.1.1

NI myDAQ Sensor Component Control

The NI myDAQ is a powerful signal acquisition device capable of a variety of electrical signal
drivers and acquisitions. The myDAQ is equipped with analog signal acquisition input (+/- 10v),
7 digital IO pins (0-5v), a common ground, and a 5v power supply. The DAQ also incorporates
audio in and out as well as a digital multimeter.

The NI myDAQ is utilized as the digital driver to control components and acquire the
phototransistor signal. The electronic control of the PPG sensor via the myDAQ is illustrated in
figure 4.3, the wire connections from the myDAQ to the sensor are connected to the front of the
board, this is done to provide a more comprehensive understanding of the electrical components,
but it is important to note that the PPG sensor is wired via pins on the back of the board. The
PPG sensor seen in figure 4.3, consists of the IR LED (black), the red LED (red) and the
phototransistor(grey), each element on the sensor is connected to the myDAQ. The myDAQ
controls the red LED via the DIO port1 and, the IR LED via DIO port2, both LEDs require a
2.2kW resistor to optimize the emission signal. The phototransistor is supplied 5v of power from
the myDAQ and then wired to ground to close the circuit. Between the phototransistor and
ground is a 10kW resistor, the signal is collected between the component and the resistor,
depicted in figure 4.3. The myDAQ collects the phototransistor signal via the analog 1+ port,
which is used for signal acquisition by the myDAQ.
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Figure 4.3: NI myDAQ (the white box) wiring diagram to the PPG sensor, the figure shows wiring on the front of the sensor, this
is for comprehension of the electronics in the actual sensor the connections are from the back. The red(red) and the IR
LED(black)s are connected to pins 1 and 2 on the myDAQ DOI out pins. The myDAQ pins providing power to the LEDs pass
through a 2.2kW resistor before powering the LEDS. The myDAQ 5v pin supplies power to the phototransistor, and the signal out
from the phototransistor is collected by the AI pin 1+ on the myDAQ. The phototransistor out passes through a 10kW resistor
before connecting with the LEDs and closing the circuit to ground.

4.1.2

LabVIEW Software Component Control

As discussed above the digital outputs (DIO pins) on the myDAQ are wired to the LEDs on the
PPG sensor, and control power to the LEDs. The LabVIEW software controls the myDAQ and
thus regulates the power supplied to the LEDs. The software is designed to drive the LEDs,
similar to how a LED driver circuit would operate in stand-alone PPG sensors. The PPG sensor
contains two LEDs and one phototransistor, and the phototransistor reacts to light from both the
660nm LED and the 940nm LED, because of this a sample-and-hold technique is needed to
collect signal from the LEDs nearly simultaneously. The sample-and-hold technique works when
the LEDs are rapidly alternating, so the phototransistor is never exposed to both LED emissions
simultaneously.
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An example of the LabVIEW software components needed to drive the LEDs, is illustrated in
figure 4.4, contains a series of local variable controls (A), timers (B) and DAQ controls (C). The
local variable control, figure 4.4-(A), is utilized to send information indicating the state of the
LEDs to other components of the LabVIEW software. The timers or wait controls, figure 4.4(B), are utilized to provide a pause in the sequence. The final component in the PPG sensor
component control, figure 4.4-(C), is the myDAQ control, the signaling between the software
and the myDAQ which provides power to the components and supplies the LEDs with power.
The DAQ controls, the blue square in figure 4.4-(C), are wired a Boolean true or false,
correlating to turning the LED on or off.

Figure 4.4: Example of sequence components in the LabVIEW software to drive the LEDs via the myDAQ. (A)Variable controls
which change the state of digital variables that represent the LEDs, this is utilized to relay information about the LED states to
other aspects of the software. (B)A timing sequence to delay the time between software actions. And (C) the blue blocks are
express Vis that relay information to the NI myDAQ and provide power to specific pins, the express Vis are controlled with true
and false Boolean commands.

The software to control the LEDs, utilizes a structure known as a sequence event, where each
component in the sequence will operate in succession (figure 4.5). The sequence begins at left
and moves from left to right through each segment in the sequence. If the sequence is placed in a
while loop, once the sequence is completed it will go back to the first segment and start over.

75

Figure 4.5: An example of a sequence designed in the LabView software; the green box encompasses the full sequence structure
which is divided into sequence sections outlined with the red box. The arrows are the beginning of the sequence structure
represents the path of the processes, the software will complete the task in each section in sequence.

Power to the LEDs is controlled by the LabVIEW program which relays signal to the DAQ and
drives the LED states. The diagram above is an example of a sequence that can be utilized to
control the LED states, and rapidly turn on and off the LEDs.

4.2

LabVIEW Signal processing

The LabVIEW software components needed to drive the LEDs was discussed above, the rapid
switching of the LED states is used in the sample-and-hold technique. This technique is utilized
so the phototransistor can collect emissions from the two LEDs, at virtually the same time. The
myDAQ receives a signal from the LabVIEW software to control the components of the PPG
sensor. The myDAQ also provides power to the phototransistor and acquires the returning signal
from the phototransistor at the analog input. Data received from the phototransistor is
manipulated in the LabVIEW software to optimize the signal. The received signal is processed
through a sample and hold technique to separate the red and IR LED data collected by the
phototransistor. The signal is amplified and filtered to exhibit the signal components and
calculate the heart rate as well as the SpO2.
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4.2.1

Sample and Hold Technique

The sample-and-hold technique is needed in the PPG sensor, because it is designed with two
LEDs and one phototransistor, capable of detecting both wavelengths of light. The technique
works by driving the LEDs to alternate states rapidly, when one LED is on the other is off. For
example if the red 660nm LED is powered on the IR 940nm LED must be off, this allows the
phototransistor to pick up light emissions from only one LED. The other processing components
of the sample-and-hold technique involves the signal being received by the photoresistor. If the
signal was not divided into two separate signals the phototransistor would detect rapid switching
between the LEDs and nothing about the red or IR LED signal could be differentiated. The
sample-and-hold technique collects the “sample” or data from the phototransistor when
indicated, and “holds” that data, until indicated to collect more data. For example when the red
LED is powered on, signal from the LED will reflect off the tissue and become detected by the
phototransistor, the signal will then be transported to the myDAQ and LabVIEW software. The
signal received will be flagged as a “red LED” signal, and stored to a “red LED” signal data
location. The “red LED” flagging will then turn off as the IR LED on the PPG sensor turns on
and the LabVIEW software flags the new incoming data as “IR LED”. An example of the
incoming PPG signal with the sample-and-hold technique is graphed in figure 4.6 below.
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Figure 4.6: The sample and hold technique utilized for a PPG sensor with two LEDs and one photosensor, the first signal (signal
1) is the phototransistor signal when the first LED is powered, and signal 2 is the signal from the phototransistor when the
second LED is powered. The software relays which LED is powered so that the incoming signal from the phototransistor is
categorized with the correct wavelength. The separate signals can then be stitched together on separate graphs as separate
signals.

If the sample and hold technique can be executed at a high enough frequency then the PPG
signals can be stitched, meaning the missing data ignored and the data for each signal is
connected to make a complete waveform instead of having gaps in the signal. Because the data is
being stitched together and gaps ignored it is critical the sample and hold switching happens at a
high rate. The calculation of SpO2 requires the AC (peak) and DC (valley) of the IR and red
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signals at the same time point, utilizing the sample-and-hold technique and the stitching of
signals supplies these data points, for both wavelengths.

4.2.2

LabVIEW Software Signal processing

The signal coming in for the phototransistor via the analog input +1 on the myDAQ, must be
manipulated to separate out the IR and red signals and evaluate the HR and SpO2 values. Below
figure 4.7 is the LabVIEW program designed to collect the PPG signals from the phototransistor
and process the data. The first aspect of the program is the signal acquisition from the myDAQ
indicated by figure 4.7-A, signal from the phototransistor is acquired by the myDAQ and
processed in LabVIEW at a rate of 10kHz.

The signal is then processed using a relay switch figure 4.7-B, the relay switch in LabVIEW is
similar to a sample-and-hold circuit, where the signals will only be acquired while the relay is
enabled. As discussed in the previous section the LED driver circuit local variable control
component enables and disables the relay switch. For example, when the red LED is on the local
variable control will signal the red-relay to turn on and the signal from the phototransistor will be
collected, and vice versa for the IR LED.

Once the signal for the IR and red LEDs are collected separately, there are passed through a
bandpass filter in the LabVIEW software figure 4.7-C. The bandpass filter is a signal filtering
control that is built into the software controls, the filtering is used to eliminate background noise
and extract only the heart rate signal. A bandpass filter operates by extracting only the desired
frequencies within the signal, defining a low pass frequency and a high pass frequency. A study
was done to evaluate the optimal low pass filter (LPF) for calculating the AC/DC ratio of a PPG
signal. The study indicated that lowering the frequency of the LPF resulted in a ratio with lower
signal to noise and decreased standard deviations (SD)[34]. The bandpass filter utilized for the
PPG sensor was set to 0.5Hz to 3Hz to extract only the frequency of signal needed.
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After the signal is filtered the smoothed data is processed in an amplitude measurement
component of the software, this component is continuously evaluating the amplitude between the
positive peak and the negative peak. By measuring the peak-to-peak components of the PPG
signal the ratio of AC/DC is extracted for both the IR and red signals. As discussed in previous
sections the AC/DC ratio is what is utilized in the calculation of the SpO2 percent. The ratios are
stored and collected for evaluation figure 4.7-E where the ratio of the IR signal will be divided
by the ratio of the red signal, to get the final ratio to evaluate the blood oxygen percentage.

A

B

D
C

d
E
d

Figure 4.7: LabView software signal manipulation and processing, starts with (A) the DAQ assistant express VI relays the
incoming data from the phototransistor from the NI MyDAQ to the LabVIEW software (B) the data from the is split into two
signals using LabVIEW express VI relays. The two signals are then collected and Filtered (C) the filter is a band pass filter with
a HPF at 0.5Hz and a LPF at 3HZ. The last express VI (D) selects the peaks and valleys of the signal correlating to the AC and
DC components.

80

Figure 4.8 applies the same signal processing from 4.7 but the signal is acquired in a case
structure to cycle through sensor states. The three states utilized in the case structure below are,
“RED”, “IR” and “DARK”, each case is a different sensor state. This provides information about
the background signal which is important for evaluation of the signal for example the
background or “DARK” signal might be different if you are in a bright room or apply more
pressure to the sensor. Figure 4.8 is divided into two sections A and B; figure 4.8-A controls the
state and signal type being processed in section B. Figure 4.8-A cycles through three states
“DARK”, “RED” and “IR” for each state a different combo box (figure 4.8-B.1) is enabled.
When figure 4.8-A is in the “DARK” state the combo box is in the “DARK” state and turns off
both of the LEDs. When figure 4.8-A is in the “RED” state the combo box drives the red LED on
and the IR LED off, and the “IR” state turns the IR LED on and the red LED off. For each state,
the correlating signal from the PPG sensor is collected, after collection the data is passed to a
relay switch to collect the IR and red LED signal figure 4.8 – B.2. The peaks of the signal are
determined and passed through the SpO2 equation (figure 4.8-B.3). The SpO2 equation was
discussed in section 5.3, and is the linear correlation between the ratio of signals and the SpO2
value.
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Figure 4.8: The PPG sensor signaling structure that controls the state of the LEDs and the collection of signal (A) the case
structure responsible for controlling the state of the signal evaluation which cycles through dark, red and IR states. These states
are relayed to the signal evaluation structure (B) where the incoming signal from the sensor is passed into the case structure
(B.1).the case structure controls the LED states and collects the signal. (B.2) processes the signals from the sensor and the last
component (B.3) is the SpO2 evaluation.

The ratio of signals is defined by the equation below:
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Equation 4.1

Where the R is equal to the ratio of the red signal AC/DC over the IR signal AC/DC. The ratio is
then implemented into the linear SpO2 equation (equation – 2.20) to calculate the blood oxygen
percentage. The LabVIEW program is capable of implementing the calculated ratio into the
SpO2 equation indicated in figure 4.8-B.3.
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4.3

Virtual instrument Monitoring

The LabVIEW contains the ability to develop a graphical user interface (GUI) to allow user
interaction with the software. The PPG sensor is equipped with the LabVIEW GUI capable of
displaying and calculating the data. The graph on the left in figure 4.9 displays the raw unfiltered
data that is collected by the sensor, on the right of this graph is the signal after being processed
through a 0.5-3Hz bandpass filter. The user can turn on the device by pressing the switch to
pulse oximeter, once the pulse oximeter is turned on the user can watch the graphs as the signal
is collected. The RED and IR green buttons indicated at the top of figure 4.9 will turn on and off
indicating which signal is being collected. The heart rate and SpO2 value will be displayed in the
box to the right. The user also has the ability to collect the data, after the user inputs the name
and trial number as well as the path location, the blue button at the top of the GUI can be pressed
and the data will be recorded for 15 seconds.
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Figure 4.9: LabVIEW programing graphical user interface at the top of the GUI in brought blue is the collect button once this is
pressed the program will collect the PPG signal data for 15 seconds. In this GUI you can enter the name and trial number as
well as the location to store the results. On the left side of the GUI is the unfiltered raw data and on the right is the filtered data
after manipulation.
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CHAPTER 5
5.0

MECHANICAL SIGNAL OPTIMIZATION

The goal of this thesis was to implement the PPG sensor into the cap of the Electronic Tuning
fork (ETF). The ETF is placed on the bottom of a patient’s foot and vibrates to indicate
neuropathy, or lack of feeling. The ETF is a hand-held rectangular instrument with a small cap
located at the base of the device which comes in contact with the foot figure 5.1.

Figure 5.1: Electronic Tuning Fork utilized in this thesis, the device is 12 inches long and fits in your hand. The device is used
for measuring diabetic foot neuropathy and the cap (indicated in figure) is placed on the bottom of your foot.

The PPG sensor for this thesis was logistically designed to fit in the cap of the ETF, to advance
patient care by providing doctors with multiple biological vitals using a single device. Figure 5.2
illustrates the ETF cap dimensions, and the maximum usable area to build the PPG sensor. The
sensor’s physical design was optimized to fit in the ETF cap and come in contact with the
patient, to take their vitals during a test.
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Figure 5.2: The cap from the ETF has a height of 15.95mm and an inner diameter of 12.6mm. The PPG sensor must fit within the
cap, so the dimensions are critical to design.

After development of a PPG sensor dimensionally compatible with the ETF cap and capable of
calculating SpO2 the objective was to optimize the PPG signal from the sensor by altering the
light attenuation using mechanical structures.

A normal pulse oximeter utilizes transmission based signaling, eliminating factors that can
negatively impact the signal in a reflective PPG sensor. The type of sensor and the
implementation of the sensor in this thesis allows for variation of applied pressure and
movement. Although reflective based sensors have variations in signal due to pressure changes
and movement, they are more optimal due to reduced limitation of use. One study that compared
the contact pressure of reflective pulse oximeters to accuracy of results, found that the increased
pressure of a sensor applied to the forehead, 12 and 27 kPa, resulted in a decrease in error and
improved measurement accuracy for both SpO2 and heart rate[41]. In contrast the study did
determine that less applied pressure, 4kPa, caused both the SpO2 and heart rate results to
decrease in accuracy, from insufficient contact and movement. Movement from the patient or
doctor can allow more or less light to reach the sensor therefore interfering with the PPG signal
received. The goal is to design an overlay on the surface of the PPG sensor PCB to optimize the
signal. The overlay is capable of directing the light through the tissue to amplify the signal and
reduce the signal to noise ratio, which compares the signal intensity to the background noise
from a signal.
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5.1

Signal to Noise Ratio

The signal to noise ratio(SNR) is a critical metric of any signal. It calculates a value representing
the amount of background noise in relation to the desired signal. Because of the PPG sensors
variation from pressure and light perfusion the SNR is an important metric to indicate how the
device is performing. The SNR formula is indicated by equation 5.1
;

𝑆𝑁𝑅 = <0(1)&2

Equation 5.1

0(1)&2

Where µ is the average signal value and s the standard deviation of the signal. An example of a
PPG signal with noise is illustrated in figure 5.3. As the amplitude is changing over time, there
are minimal variations in amplitude throughout the signal, which is the noise.

Figure 5.3: Example of a PPG signal containing noise, where the small variations in amplitude represent noise in the signal and
the larger changes in amplitude are the desired signal.

The PPG signal fluctuates in amplitude, representing the pulsatile signal of blood perfusion. As
discussed in previous sections the PPG signal has an AC and DC component, representing the
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peak and valley respectively. Both components can have fluctuating SNR because they represent
different parts of the tissue. Evaluating both the AC and DC components of the signal that SNR
ratio becomes:
𝑆𝑁𝑅 =

;345 ;/4
<345/4

Equation 5.2

Where the SNR becomes the average AC signal minus the average DC signal over the standard
deviation of AC minus DC, and the equation for the standard deviation becomes:

𝜎&(/-( = 8𝜎&( ! − 𝜎-( !

Equation 5.3

Where the standard deviation of the signals is the sum of squares of the components.

The SNR is an important component to optimize the PPG signal, the goal is to decrease the ratio
having a high signal and low noise. The filtering discussed in the previous section will remove
some of the noise from the PPG signal, but the signal can be further optimized by evaluating the
SNR of the raw signal. As the various cap structures are utilized the SNR of the raw signal can
be evaluated to determine how well the cap is optimizing the data.

5.2

Structures

Three caps were designed to fit over the PPG sensor and direct the LED and phototransistor
different directions to optimize the PPG signal. The three designs can be seen in figure 5.4,
where all caps were designed with a crevice in-between the LEDs and phototransistor intended to
allow more tissue to fill between the optical components. The goal was to design the cap to
maximize the amount of light from the LEDs to interact with the tissue and return to the
phototransistor. The first cap design, figure 5.4-A, is designed with the outlet for the LEDs and
the inlet for the phototransistor directed straight up, this is the control design, the middle of the
cap is carved out to maximize the tissue between the components. The second cap design, figure
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5.4-B, has the outlets for the LEDs directed inwards and the phototransistor inlet directed
inwards. The concept behind the second cap design is for more light reflected off the tissue to
reach the phototransistor, hence both components directed toward the midline. The third and
final cap design, figure 5.4-C, is constructed to direct the light and phototransistor away, the
concept for this design is to allow the light to travel further into the tissue before returning to the
phototransistor. The third design is constructed to reduce signal to noise ratio and eliminate light
bleeding for the LEDs to the phototransistor before reaching blood components.

Figure 5.4: Initial cap overlay designs, constructed to direct light and optimize PPG signal all constructed with the same
dimensions as the (A) is designed to project light from the LEDs directly out

The caps were designed using Solidworks© a CAD (computer-aided design) modeling software.
After design the caps were printed using Ultimaker 2+TM a 3D-printer capable of printing
approximately 2.58mm. Due to the size and complexity of the caps constructed for the PPG
sensor and the limitations of the 3D printer, the caps designed to direct light outward and inward,
figure 5.4-B&C, could not be printed successfully. Although the cap design with the light
attenuation directed straight, figure 5.4-A, was able to be printed the pulsatile signal was not
detected when this cap was utilized on the sensor.

The above cap designs were simplified to determine why there was no signal seen when using
the first cap designs figure 5.4-A and if a similar cap could help determine the problem and
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optimize the signal. Figure 5.5 shows the next stage of caps designs tested on the PPG sensor.
The first is the PPG sensor contains a signal divider between the LEDs and the phototransistor,
the second contains a full cap encompassing all the components, and the third is a sensor with no
obstruction to the optical components.

Figure 5.5: The two modified versions of the PPG sensor and the bare PPG sensor for testing.

The final cap designs tested are illustrated in figure 5.5. All of the caps are constructed using
Solidworks© and 3D-printed on the Ultimaker 2+TM using black PLA material.

The first design is the “Middle Divider”, figure 5.6, designed with a divider between the LEDs
and the phototransistors on the PPG sensor. The divider design is constructed with intentions of
eliminating light bleeding from the LEDs into the photosensor without first entering the tissues.
The black middle divider will force the LED emission into the tissues, in turn causing the only
light reflected from the blood to hit the phototransistor. The middle divider is constructed as a
rectangle with dimensions of 11mm x 3.5mm x 2mm to fit between the components on the
sensor, and the 2mm height is greater than the height of the optical components, to eliminate any
light attenuating over.
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Figure 5.6: Middle Divider cap design

The “Full Cap” illustrated in figure 5.7, is constructed with the same dimensions as the PPG
sensor, with cut outs for each of the optical components. The full cap design surrounds each
component with a 2mm height, the cap will not only eliminate all light bleeding from the LEDs
but also eliminate any ambient light hitting the photosensor.

Figure 5.7: Final cap design

The final test will be the PPG sensor with no physical additions to the surface, figure 5.8, this is
the control design and there is no attempt to optimize the light attenuation. The PPG signal
collected from the phototransistor will be the raw signal, when a finger is placed directly on the
surface.
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Figure 5.8: No Cap

The Middle divider and the final cap design are constructed to optimize the light reaching the
sensor. The goal is to not only increase the light attenuation into the tissues, but also the reflected
light from the tissues to the phototransistor. These designs attempt to force the light from the
LEDs into the tissues and eliminate bleeding of light to the phototransistor. The full cap design
also aims to decrease any light sources in the testing area that might attempt to affect the signal
received by the phototransistor.

5.2

Test Methods

The caps are constructed to optimize the light attenuation from the tissues to the phototransistor
on the sensor. The goal is to increase the amount of light from the LEDs reaching the blood and
the amount of light reflected back to the phototransistor. Each mechanical cap was added to the
sensor and secured to ensure no movement during the testing. The right index finger was applied
to each sensor with comparable force, and data from the PPG sensor was collected. The subject
was asked to place a digit on the sensor for approximately 10 seconds to ensure heart rate could
be easily identified in the signal and calculated. The signal received from the PPG sensor was not
filtered, to allow for optimization of the raw signal. The voltage variation was analyzed to
determine which design optimized the signal. During the testing the PPG waveform signal was
acquired using only the IR LED, because of its higher attenuation through the tissue and stronger
signal projection. The PPG sensor was controlled through the NI myDAQ, powering the LED
and controlling the phototransistor. The data was collected through the myDAQ and the signal
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was visualized using the LabVIEW software. The signal evaluated was the raw signal collected
directly from the phototransistor, where the amplitude reflects the voltage variation.

5.2

Results

The amount of light attenuation into the tissues and reflected back to the phototransistor can be
determined by evaluating the raw voltage signal from the PPG sensor. The waveform represents
the blood perfusion as a result of the heartbeat, and the extent of the signal can be a result of light
perfusion through the tissues.

5.2.1

Proposed Results

The waveform signal produced from the PPG sensor, describes how the light is attenuating
through the tissue and reaching the phototransistor. The signal from the phototransistor is
collected in LabVIEW and a graph of the waveform is displayed. The signal amplitude, and the
AC signal height, range of peaks and valleys in the pulsatile signal, provide information about
movement of light from the LEDs to the phototransistor. High amplitude signals indicate that the
phototransistor is receiving a large quantity of light, this could be caused by high reflection of
light off the tissue or bleeding of light from the LEDs directly to the phototransistor. On the
contrary low amplitude signals indicate minimal light is hitting the sensor.

When the light from the LEDs is hitting the tissue and reflecting back to the phototransistor, it is
optimal, and the PPG signal will look like figure 5.9. In this graph the PPG waveform has a high
amplitude and a high signal height. The high amplitude represents the phototransistor is
receiving a large quantity of light, and the high signal height indicates that the light is reflected
from blood volume changes.
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Figure 5.9: PPG signal with high amplitude and heigh signal height, this is the optimal signal output for a PPG sensor, because
it reflects the light hitting the blood vessels in the tissues and reflecting back to the photosensor.

In figure 5.10 the PPG signal contains a high amplitude, but the signal height is small. The high
amplitude illustrates the high incidence of light hitting the phototransistor, but the low signal
height indicates the light is not reflected off the blood. In this instance there is a great deal of
light hitting the phototransistor but not a lot of the light is reflected off the blood in the tissues.

Figure 5.10: PPG signal where the amplitude is high, but the signal height is low, indicating high amount of light reaching the
phototransistor but not high light attenuation through the tissues.
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If the signal received from the PPG sensor, has a low amplitude and a low signal height, seen in
figure 5.11. In this instance the extent of light hitting the phototransistor is low, represented by
the low amplitude, and the light that is hitting the phototransistor is not reflected off the blood in
the tissues. Light from the LEDs is not hitting the blood and picking up variations in blood
volume and the phototransistor is not receiving any reflected light.

Figure 5.11: PPG signal where the amplitude is low and the signal height is minimal, indicating less light reaching the
phototransistor and no light attenuating through the tissue.

When designing these caps, the goal is to optimize the raw signal from the phototransistor on the
PPG sensor, to do this the signal should look like figure 5.9 where the amplitude is high, and the
signal height is high. This signal illustrates high attenuation light through the tissues and
increased light reflecting back to the PPG sensor.

5.2.2

Design Results

The two PPG sensor cap designs and the stand-alone PPG sensor that were tested can be seen in
figures 5.6-8.
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5.2.2.1 Middle Divider Cap Design
The first cap tested was the middle divider seen in figure 5.6, the part was made to fit between
the LEDs and the phototransistor on the PPG sensor, and block excess light hitting the
phototransistor from the LEDs. After the LED was eliminated the index finger was placed on the
sensor and the data from the phototransistor was collected from the myDAQ and recorded using
the LabView software. The results can be seen in figure 5.12, the graph indicates the amplitude
of signal is 0.1, this is the voltage that is received from the phototransistor, representing the light
hitting the sensor.

Time (s)

Figure 5.12: Middle divider cap design with an amplitude of 0.1v.

5.2.2.2 Full Cap Design
The next cap test is the full cap design, as seen in figure 5.7, is designed with the intent to fully
encompass the sensor components. The cap is constructed to perfectly sit on top of the PPG
sensor with cutouts for the LEDs and the phototransistor. The signal from the PPG sensor with
the full cap design can be seen in figure 5.13, where the amplitude is low, approximately 0.05v.
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The low amplitude indicates that there is minimal light hitting the phototransistor. When looking
at the signal height it can be concluded that there is no visible heartbeat.

Time (s)

Figure 5.13: Full Cap design signal received from the PPG sensor with minimal amplitude at 0.04v.

The low amplitude indicates that the light coming from the LEDs is not penetrating into the
tissues to pick up any signal involving blood perfusion. Because the phototransistor is not
receiving any light signal there is no indication that the LEDs are not penetrating deep enough
into the tissues. The signal height could be non-existent in the PPG signal because no light is
hitting the phototransistor.

5.2.2.3 No Cap Design
For comparison, the same test was performed on the PPG sensor without any cap addition,
design illustrated in figure 5.8. The signal results for the stand-alone PPG sensor can be seen in
figure 5.14. The figure illustrates a high amplitude, of about 0.2v this indicates the
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phototransistor is receiving high attenuation of light from the LEDs. Also indicated in figure 5.8
is the increased signal height, which is greater than the capped sensors.

Time (s)

Figure 5.14: No Cap PPG sensor signal has a high amplitude of 0.2v.

The signal increase in decrease is related to the light variation from the blood volume changes.
The raw PPG signal received when the index finger is laid directly on the PPG sensor has a high
signal height and high amplitude, concluding the light reaching the phototransistor is reflecting
from the vascular bed of the tissue.

Comparing the amplitude results for each sensor design, the middle divider PPG signal had an
amplitude of 0.1v, the full cap, 0.05v, and the PPG sensor with no cap was 0.2v. Figures 5.12,
5.13 and 5.14 illustrate the amplitude recorded for the three sensors tested. The full cap design
had the lowest amplitude indicating it was receiving the least amount of light from the LEDs, the
middle divider had an amplitude between the full cap and no cap, thus receiving some light. The
PPG sensor with no cap had the highest amplitude and was receiving the more from the LEDs. In
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this instance it can be concluded that the PPG sensor with no cap is the most optimal for
receiving more light, and the addition of the cap limits the sensor’s ability to reflect and collect
the light.

Comparing the signal heights which provide some indication as to how well the LEDs are
projecting light in the tissue, is a factor that adds to the optimization of the signal. For each cap,
figure 5.15, shows the pulsatile signal, demonstrating the extent of light reaching and reflected
off the vascular bed. The full cap sensor, figure 5.15-A, has no pulsatile signal, and the
phototransistor is not detecting light that is reflected from the blood perfusion. The middle cap
design, figure 5.15-B indicates possible pulsatile signals from blood volume changes, the
heartbeat is somewhat visible in the signal. The PPG sensor with no cap design, figure 5.15-A,
has a high signal height, reflecting the light variations from the blood volume changes, the
pulsatile PPG signal.
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Figure 5.15: Signal height evaluation for the PPG sensor cap types. (A) the PPG sensor with no cap the correlating signal is
significant, and the pulsatile signal can be clearly identified. (B) The PPG sensor with the middle divider, this signal contains
minimal signal height, and the pulsatile signal can only somewhat be identified. (C) The PPG sensor with a full cap design has
no signal height and the pulsatile signal is not present.

The PPG sensor cap designs did not reflect the desired outcome, both the full cap and middle
divider indicated low light reaching the phototransistor, and light projection from the LEDs into
the tissues was minimal. Compared to the PPG sensor with no cap the, two cap designs did not
optimize the signal outcome like initially intended. It was concluded that the most optimal signal
would be produced from a PPG sensor with no cap design, and the best results would come from
placing the tissue directly on the sensor.
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5.3

Theory

The question is why did the PPG sensor with no cap produce a better raw PPG signal than the
sensors with the cap designs. The theory is skin from the fingertip is falling between the
phototransistor and the LEDs, seen in figure 5.16. The PPG sensor is designed with 4mm of
space between the phototransistor and the LEDs, when the subject places the finger over the
sensor skin falls between the components.

Figure 5.16: The designed PPG sensor cross section with a finger being placed over the sensor to show how the tissue of the
finger can seep between the phototransistor (PT) and the LEDs on the sensor when there is no cap or mechanical obstruction
between the components.

This changes the PPG sensor from a reflective based PPG sensor to a transmission-based sensor,
discussed in chapter 2.3.4. In a transmission-based sensor the light from the LEDs attenuates
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through the tissues to the phototransistor opposite. In this case the light projected from the LEDs
is forced to pass through the tissues and absorb into the blood, because the phototransistor is on
the opposite side the light that is not absorbed is directly projected to the phototransistor. This
optimizes both the light signal attenuation through the tissue, and the reflected light reaching the
transistor. For concept to be functional the skin depth capable of fitting between the components
must contain blood vessels with blood perfusion. The skin that the light attenuates through must
have information about blood volume changes. To calculate if this is possible, the LED height
and the vascular tissue bed depth must be compared.

The PPG sensor that was tested is PPG sensor 2, discussed in chapter 3.2, and the optical
components utilized are discussed in chapter 3.2.1. Both the IR and red LED have a height of
1.6mm and the phototransistor has a height of 1.7 mm. There are other factors such as tension
and resistance of the skin that most likely impact the amount of tissue capable of fitting between
the components, but the maximum, due to the optical component height, is 1.7mm. Now that the
height of tissue that can fit between the components is determined, the depth of the skin
containing the capillaries must be within 1.6mm. A study was completed to test the extent of skin
thickness in response to various physical circumstances, such as vibrational and thermal signals.
The study evaluated the thickness of the epidermis layer using an ultrasound. Although the study
was to evaluate the difference in epidermis thickness in response to thermal and vibrational
signals, the skin thickness throughout the study did not exceed 1mm[42]. The average skin
epidermis thickness on the right index finger was found to be 0.57 (+- 12 SD)[42]. Because the
depth of tissue containing capillaries is approximately 0.57mm below the skin surface (0.69mm
at max) and the height of the optical components is 1.6mm, the skin falling between the optical
components on the sensor is completely possible. In this case the transmission of light, through
the vascular tissue between the optical components to the phototransistor would be more direct,
resulting in a high amplitude and signal height in the PPG signal.
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CHAPTER 6
6.0

CONCLUSION

Throughout my master’s thesis at the University of Maine, a reflective based
photoplethysmography sensor was designed and developed. With the help of the electrical
department and the bioengineering staff I was able to construct a working prototype capable of
detecting heart rate and calculating blood oxygen saturation. There are a few topics I would like
to reflect on within this project; first I would like to discuss testing that I would have performed
had I been able to access the resources, second I will reflect on the aims of this thesis and my
accomplishments within those aims, and finally I want to discuss future work for this device and
potential prospective projects.

6.1

Testing Intentions

The intention was to proceed with additional testing, evaluating the heart rate and SpO2
calculations from the designed PPG sensor to determine if the sensor was proficient. Because of
restrictions due to the COVID-19 pandemic this testing was limited, and comparing blood
oxygen percentages across multiple subjects was not feasible. It was intended to prove that the
PPG sensor designed in this thesis was capable of acquiring heart rate data and calculating the
SpO2 value, within 2% SD of SaO2 which is the claimed accuracy for most manufactured pulse
oximeters[36]. The intention is to compare the PPG sensor’s acquired heart rate and SpO2 value
to other on market pulse oximeters. The SpO2 value is calculated from the heart rate, which
directly correlates to the light attenuation through the tissues and back at the sensor. The PPG
signal result of the light projecting through the tissue and reflecting back to the photosensor is
illustrated in figure 5.10 and defined by a height amplitude with a high signal height.

6.1.1

Intended Heart Rate and SpO2 Testing Methods

When determining the protocol for my PPG sensor evaluation I wanted to utilize similar
techniques that have been executed in the literature, keeping in mind my intentions for the study.
The amount of people, blood oxygen saturation, skin type, age, and health were all important
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components to be considered when designing the study, and often incorporated into the work of
others. Many studies compare a personally designed PPG sensor to other pulse oximeters on the
market, as well as the results of an arterial blood gas test. Although an arterial blood gas test
takes time, and blood oxygen saturation can change rapidly, many studies utilizing this as a
comparative technique, record the time of blood withdrawal. Another study I found interesting,
which tested the ability of a PPG sensor to calculate blood oxygen saturation, utilized an ice
water bath to decrease the blood flow to the tissues[43]. This method changes the PPG signal but
the SpO2 value and the calculation of that percentage remains constant. The study evaluates the
accuracy of the PPG sensor when the skin temperature is colder than normal. There are many
studies in the literature that evaluate the accuracy of PPG sensors, and after thorough research of
many, I was able to construct a comparable testing method for the sensor designed in this thesis.

The testing would have included approximately 10 subjects with SpO2 values ranging from 75%
to 100% , similar to a study done in 2018 that compared two reflective PPG sensors at various
locations on the body[44]. The study utilized 10 patients with various SpO2 values, ages, medical
conditions and skin tones. The study compared the pulsatile signal of multiple PPG sensors, to
the sensor designed in the study, by calculating and comparing the R-value. The designed sensor
SpO2 value was also compared with the other sensors testing in this study. My intention is to
design my study similar to this with comparable parameters and evaluation methods.

Study objectives
•

The objective is to investigate feasibility of thesis designed PPG sensor by measuring
heart rate and calculating SpO2 values taken from the foot of the patient.

•

Compare pulsatile differences between thesis designed PPG sensor and comparable
sensors to evaluate efficiency.

Intended Study Methods
•

Acquire information about the subject age, gender, weight, skin tone, medical conditions
and average blood oxygen saturation.
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•

Attach designed PPG sensor to the right foot on the bottom of the big toe (figure 6.1).

•

Attach two different, commonly used transmission-based PPG sensors (pulse oximeters)
to right and left index fingers.

•

Attach and secure reflective-based forehead PPG sensor to subject’s forehead.

•

Acquire data through the NI myDAQ and LabVIEW software for all of the sensors
utilized in the study, for a total of 3mins.

•

Once 3mins is completed, remove all sensors

•

Draw blood and run arterial blood gas test
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Figure 6.1: Designed PPG sensor placed on the bottom of the big toe in the study for testing.

Study Results Comparison
To compare the performance of the designed PPG sensor to the other sensors tested the R-value
will be calculated from the pulsatile signal. The R-value is a ratio of the peaks and valleys from
the signal and represents the PPG waveform. The signal for all of the sensors is collected on
LabVIEW, and the calculations of the R-value are executed in the software as well. An example
of how this data is compared for each sensor is seen in table 6.1. The R-value is calculated by
extracting the AC and DC component from the PPG signal and taking the ratio of the
components with respect to the dark signal, discussed in section 2.4.3.
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Table 6.1: Example of R-Value comparison table that would exist for the PPG sensor testing and evaluation

R-Value
Subject ID

Right Finger

Left Transmission

Commercial

Right Transmission

Transmission Pulse

Pulse Oximeter

Forehead PPG

Pulse Oximeter

Oximeter

Sensor

001
…
010

The R-value is utilized in calculating the SpO2 values, which would also be compared for each
one of the sensors and the arterial blood gas test, an example of this data is seen in table 6.2.

Table 6.2: Example of SpO2 comparison table that would exist for the PPG sensor testing and evaluation

SpO2 Percentage
Subject ID
Arterial Blood
Gas Test

Right Finger

Left

Commercial

Right

Transmission

Transmission

Forehead PPG

Transmission

Pulse Oximeter

Pulse Oximeter

Sensor

Pulse Oximeter

001
…
010

Further analysis of the values would be to correlate the data in a graph and evaluate the
performance of the designed PPG sensor. The results from the PPG sensor should correlate to the
other devices tested and no outliers or variations in the data should be apparent. The PPG sensor
would be deemed feasible if the sensor correlation was no greater than 2 standard deviations
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from the correlation of the over PPG sensors. An example of the PPG sensor SpO2 valves
compared to the other sensors across the 10 patients can be seen in figure 6.2

Blood Oxygen Saturation Variation

Blood Oxygen Saturation (SpO2)

100
98
96
94

Arterial Blood gas
Left Pulse Oximeter

92

Right Pulse Oximeter

90

Forehead Sensor

88

Designed PPG sensor

86
84
1

2

3

4

5

6

7

8

9

10

Paitent Number

Figure 6.2: An example of a graph illustrating the results of the arterial blood gas test, left pulse oximeter, right pulse oximeter,
forehead sensor, and the designed PPG sensor SpO2, across the 10 patients

From the data collected on the SpO2 results the percentage of error can be calculated using the
equation below:
𝐸𝑅𝑅𝑂𝑅 =

|789|
|9|

𝑋 100%

Equation 6.1

Where the percent error is the absolute value of the experimental results minus the theoretical
results over the theoretical result time 100. The error represents how far the expected value is
from the tested value. To compare the designed PPG sensor results to the other 4 methods of
measuring blood oxygen in the study the experimental error is always the designed sensor results
and the theoretical would be the compared sensors. Evaluation of error indicates how far the PPG
sensor values differ from the other sensors, and example of a graph representing the percent error
of the sensor is illustrated in figure 6.3
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Figure 6.3: An example of the PPG sensor’s calculated percent error of SpO2 for each patient compared to the other sensors
SpO2 results.

6.2

Evaluation of Thesis Aims

The first aim in this thesis was to successfully design a reflective based PPG sensor capable of
detecting blood oxygen saturation. The PPG sensor was designed with the intention of fitting
into the cap of the ETF (figure 5.1 and 5.2), and thus constrained inside to 13mm in diameter.
The size restriction was one of the most difficult aspects of this project, the initial thought was to
fit the majority of the electronic components for the PPG sensor within the cap of the EFT. This
is seen in the initial circuit board sensor design where the resistors needed in the circuit are
equipped on the bottom of the PPG sensor. Upon further analysis of the electronics and what
would be needed to fit and operate in the cap of the ETF it was determined, with the help of the
electrical engineers, that the sensor could be reduced in size if constrained to only the core
optical components on the PCB. Because the sensor has more components than just the core
optical components, the intention was to wire the optical components in the cap through the base
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of the ETF cap and onto the main control board, where more electronics could be constructed for
the device. The intention was to design and optimize the PPG sensor outside of the ETF and then
integrate the hardware and the electrical components into the device.

The second thesis aim was to optimize the PPG signal from the sensor by manipulating the
design of the cap to enhance the light attenuation. This aim encompassed the majority of the
work and analysis I performed with the sensor design. The intention was to optimize the PPG
signal, as discussed in the previous sections the cap designs did not yield the initial intended
result. The cap was initially designed to replace the entirety of the ETF cap and was constructed
with those dimensions (figure 5.2). From the past chapters it is known that the initial caps,
intended to replace the ETF cap, produced no signal and further design and testing was needed.
The next stage of designs were not constructed with the intention of replacing the current EFT
cap but to evaluate why the initial cap designs did not optimize the signal. The final caps designs
provided useful information about the PPG sensor and its performance. It was determined that
the signal from the PPG sensor was optimized when there was no cap or covering around the
optical components, the PPG sensor with no cap produced the most optimal signal, and should be
utilized as the final design in future testing.

6.3

Future Work

With the inability to complete all of the future work for this project due to time and unforeseen
circumstances. I think it is important to express future work for this project and further
functionality that can be incorporated into the PPG sensor and the ETF device. The intention of
this thesis was to completely install the PPG sensor into the cap of the tuning fork. Future work
would have encompassed installing the sensor in the ETF cap such that the installation caused no
adverse effects to the original ETF vibrational functionality, and the PPG sensor was able to
collect accurate data from the patient. Installing the PPG sensor into the ETF entailed working
with the electrical engineering department to program a motherboard to control the device and
integrate it into the ETF electronics.
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6.3.1

Integration of Sensor into ETF

The intention of the thesis is to incorporate the designed PPG sensor into the ETF cap. The
intention was to design the optimal reflective based PPG sensor that is compatible with the ETF
design, once the PPG sensor was optimized it would be integrated into the device. First the PPG
sensor would have to be strategically incorporated in the ETF cap with wiring to the main control
board. The sensor and the wires would have to incorporate in the device and not cause any
negative effect on the vibrational signal. Because the goal is to take the electronic tuning fork,
which has the ability to vibrate and test diabetic neuropathy, and add the ability to monitor blood
oxygen saturation, any obstruction to its initial function would be adverse. The intention was to
install the PPG sensor into the cap of the ETF with wiring that travels through the cap and up to
the motherboard. The electronics in the motherboard of the ETF would be designed to control the
sensor and relay SpO2 data through the ETF monitor.

Future work is needed to integrate the sensor into the ETF cap. The thesis work involved,
constructing different ETF cap designs to optimize the PPG signal, but It was determined that the
most optimal PPG sensor was the sensor without any obstruction to the optical components.
Work is needed to incorporate the sensor into the the ETF cap without inhibiting the emission
and detection aspects of the sensor. Integration must involve containing the sensor within the
ETF cap and keeping the LEDs and the photosensor exposed to be placed directly on the skin.
The electronic tuning fork is a medical device that must be used between patients so some type
of protective layer must be incorporated to the sensor. This protective layer will act as a barrier
between the sensor and the tissue, but it is critical that this addition does not affect the sensor
emissions.

6.3.2

Signal Optimization for Integration

Currently the PPG sensor is designed where the electronic components are controlled via the
LabVIEW software and NI myDAQ but to integrate into the ETF an external motherboard would
have to be utilized to control and collect data from the sensor. The intention was to use the NI
myDAQ and LabVIEW software to optimize the LED control and signal manipulation for the
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PPG sensor, and then convert that into electronics. All of the components of the sensor control
and signal processing within the software must be analyzed to determine the most optimal
settings for acquiring the PPG sensor. This entails optimizing; the frequency of signal
acquisition, rate of LED state switching, length of time LED signal acquired, high pass filter,
lowpass filter and, extent of signal collection needed for SpO2 evaluation. The LabVIEW and NI
myDAQ control system should be utilized to evaluate the effect of changing each signal
manipulation component.

The first component is the rate of frequency of signal acquisition, this is dependent on the rate of
acquisition of the phototransistor, and the NI myDAQ in this case. Future work will involve
converting the signal components to electrical parts, so the frequency of acquisition will not be
restricted to the rate of the DAQ, but rather the rate of the electrical components and
motherboard.

The next signal component to be optimized is the rate of LED switching and the time each LED
signal should be acquired. The sample and hold technique, utilized in the PPG sensor, is
optimized by increasing the rate of attenuation between the LED states, because the PPG signal
will have smaller gaps in the data between “switching”. The rate at which the LEDs can be
switched to power on and off is only restricted by the time of acquisition of the phototransistor,
or the rise and fall time. For the particular phototransistor utilized in the sensor the rise time is
0.11ms, and represents the time it takes for the phototransistor to respond to the light, and the fall
time is 0.22ms and is the time it takes the phototransistor to stop responding to light. Those two
characteristics of the phototransistor must be accounted for when optimizing the rate of the LED
switching.

Most all PPG sensors utilize high and low pass filters to extract the pulsatile signal and remove
noise. The filters are utilized to eliminate the high and low frequency signals from the pulsatile
signal of the heart rate. The high and low pass filters needed for a PPG sensor can be determined
with an understanding of a normal heart rate signal. The current PPG sensor designed utilizes
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high and low pass filters of 3Hz and 0.5Hz, respectively, and were determined as a result of
biological heart rate. The lowpass filter at 0.5Hz would correlate to a heart rate of 30bpm, which
is not biologically possible, and the high pass filter of 3Hz correlates to a heart rate of 180bpm.
For future work these filters could be optimized to be more inclusive or exclusive of the PPG
signal representing the heart rate.

The final signal component is the minimum amount of data needed to calculate the SpO2. As
discussed in previous chapters the SpO2 calculation relies on the AC and DC components of a
PPG signal. As we know the AC and DC components of the signal correlate to the systole and
diastole cycles of the heart beating, and thus to make one SpO2 calculation the heart must
complete one cycle. Although this is the minimum time and signal needed to make the blood
oxygen calculation, more data utilized for the calculation has been known to produce more
accurate results. This is a component of the signal processing that could be optimized in future
work to produce more accurate SpO2 results.

Each signal processing component should be tested by changing their values and evaluating how
the PPG signal amplitude, signal height and SNR change in response to the changes. The
LabVIEW software and NI myDAQ provides easy control of the signal components allowing
future work developing a more optimized signal. Once each component is optimized to produce
the desired PPG signal, the control and signal manipulation, the device will be converted to
electrical components and a central processing unit (CPU).

6.3.3

Electrical Integration

Future work will require working with the electrical engineering department to take my
LabVIEW software and component control and build that into an external motherboard to be
installed in the ETF. The external motherboard is capable of controlling the LEDs as well as
acquiring and evaluation the PPG signal to calculate the SpO2 value. As I do not know much
about the electrical conversion from signal manipulation, additional help from others with a more
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in-depth knowledge of electronics would be needed. The components such as high pass filter and
signal control can be built into electrical components on a PCB. Future work would involve
investigating the most optimal way of taking the components determined from the LabVIEW
software and converting them into electronic components that can be incorporated into the ETF
device.

The PPG sensor control and signal evaluation components would have to be combined on a
signal PCB that could be incorporated into the ETF. This would require further evaluation of the
ETF and how the device operates. The frequency at which the device controls the components
would need to be determined as well as the voltage that is supplied from the batteries to the
electrical components. The PPG installation would require variations to the sensor electronics
depending on the supply voltage and the device frequency. Once the PPG electronics are
optimized to incorporate with the device, further electronic integration is needed to merge the
ETF screen to project the results from the PPG sensor. An analog to digital converter would be
required to process the signal and produce a result that could be utilized and integrated into the
ETF screen.

6.3.4

Final Sensor Integration

Once all aspects of the sensor have been optimized the integration into the ETF must be
finalized. First the sensor must be mechanically integrated into the ETF cap. This includes
installing the sensor so that the optical components are exposed on the tip of the cap. They sensor
must fit sufficiently in the cap such that it can be placed on the tissue of a patient with mild
pressure applied. The exposed sensor requires a covering to facilitate sanitary exchanges from
patient to patient. The sensor covering will also illuminate electronic exposure and decrease
failures as a result of exposure to the elements. Once integrated and the sensor signal processing
components are optimized the sensor must be converted to a motherboard and central processing
unit. The motherboard of the sensor must be compatible with the ETF electronics, operating at
the same voltage, and small enough to fit within the sensor. Wiring from the PPG sensor in the
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cap to the mother board integrated into the ETF device, must be done such that there is no effect
on the vibrational mechanics of the tuning fork.

After all of the mechanical and electrical integrations are completed the final processes requires
alterations to the ETF. The tuning fork operates with a single function, performing the
vibrational sensation test. The ETF must be altered to incorporate blood oxygen saturation
monitoring functionality. Future work would involve integrating a new “Mode” into the tuning
fork so the user could change the evaluation method. If the examiner wanted to test the blood
oxygen saturation, there would be a button to do so and the device would turn on the sensor to
collect PPG data. The signal acquired from the sensor would be evaluated in the ETF and
projected on the device’s display monitor. This would be the finial component needed to
integrate the sensor into the electronic tuning fork such that the device could monitor blood
oxygen saturation and peripheral neuropathy on the same handheld device.
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